Document:

Warrant to Purchase Shares of the Preferred Stock

 Exhibit 4.3 
 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN
EF’F’ECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL (WHICH MAY BE INHOUSE COUNSEL) REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY
APPLICABLE STATE SECURITIES LAWS. 
 WARRANT AGREEMENT 
 To Purchase Shares of the Preferred Stock of 
 TRULIA, INC. 

Dated as of September 15, 2011 (the “Effective Date”) 

WHEREAS, Trulia, Inc., a Delaware corporation (the “Company”), has entered into a Loan and Security Agreement of even
date herewith (the “Loan Agreement”) with Hercules Technology Growth Capital, Inc., a Delaware corporation (the “Warrantholder”); 
 WHEREAS, the Company desires to grant to Warrantholder, in consideration for, among other things, the financial accommodations provided for in the Loan Agreement, the right to purchase shares of Preferred
Stock (defined below) pursuant to this Warrant Agreement (this “Agreement”); 
 NOW, THEREFORE, in consideration of
the Warrantholder executing and delivering the Loan Agreement and providing the financial accommodations contemplated therein, and in consideration of the mutual covenants and agreements contained herein, the Company and Warrantholder agree as
follows: 
 SECTION 1. GRANT OF THE RIGHT TO PURCHASE PREFERRED STOCK. 

For value received, the Company hereby grants to the Warrantholder, and the Warrantholder is entitled, upon the terms and subject to the
conditions hereinafter set forth, to subscribe for and purchase, from the Company, up to the aggregate number of shares of fully paid and non-assessable shares of the Preferred Stock as is equal to the quotient derived by dividing
(a) $1,025,000 by (b) the Exercise Price (as defined below), rounded down to the nearest whole share, in accordance with the schedule set forth below (the “Warrant Shares”): 

(i) Closing Date. The aggregate number of shares of Preferred Stock that the Warrantholder may initially subscribe for and
purchase under this Agreement shall equal to the quotient derived by dividing (a) $268,750 by (b) the Exercise Price. 

(ii) Future Term Loan B Advances. When the Company borrows Term Loan B Advances (as defined in and pursuant to the Loan Agreement)
in excess of $1,250,000, then the aggregate number of shares of Preferred Stock that the Warrantholder may subscribe for and purchase under this Agreement shall be increased on each applicable Advance Date (at which or following which the Company
borrows Term Loan B Advances in excess of $1,250,000 in the aggregate) by an amount equal to the quotient derived by dividing (a) the product of (i) the quotient derived by dividing the amount of the Term Loan B Advances borrowed on the

 
applicable Advance Date (but only to the extent of such amount in excess of the first $1,250,000 of Term Loan B Advances) by $3,750,000, and (ii) $206,250, by (b) the Exercise Price,
rounded down to the nearest whole share. 
 (iii) Future Term Loan C Advances. When the Company borrows Term Loan C
Advances (as defined in and pursuant to the Loan Agreement), then the aggregate number of shares of Preferred Stock that the Warrantholder may subscribe for and purchase under this Agreement shall be increased on each applicable Advance Date by an
amount equal to the quotient derived by dividing (a) the product of (i) the quotient derived by dividing the amount of the Term Loan C Advances borrowed on the applicable Advance Date by $10,000,000, and (ii) $550,000, by (b) the
Exercise Price, rounded down to the nearest whole share. 
 The number of Warrant Shares and Exercise Price of such Warrant
Shares are subject to adjustment as provided in Section 8. As used herein, the following terms shall have the following meanings: 
 “Act” means the Securities Act of 1933, as amended. 

“Charter” means the Company’s Articles of Incorporation, Certificate of Incorporation or other
constitutional document, as may be amended from time to time. 
 “Common Stock” means the
Company’s common stock, $0.0001 par value per share; 
 “Exercise Price” shall mean, at the
option of the Warrantholder, the lesser of (a) $2.8246 per share, subject to adjustment pursuant to Section 8, if Preferred Stock means Series D Preferred Stock, and (b) the price per share of Next Round Stock paid by investors in the
Next Round, subject to adjustment pursuant Section 8, if Preferred Stock means Next Round Stock. 

“Initial Public Offering” means the initial underwritten public offering of the Company’s Common
Stock pursuant to a registration statement under the Act, which public offering has been declared effective by the Securities and Exchange Commission (“SEC”); 

“Merger Event” means a merger or consolidation involving the Company in which the Company is not the
surviving entity, or in which the outstanding shares of the Company’s capital stock are otherwise converted into or exchanged for shares of capital stock of another entity. 

“Preferred Stock” means the Series D Preferred Stock of the Company and any other stock into or for which
the Series D Preferred Stock may be converted or exchanged, and upon and after the occurrence of an event which results in the automatic or voluntary conversion, redemption or retirement of all (but not less than all) of the outstanding shares of
such Preferred Stock, including, without limitation, the consummation of an Initial Public Offering of the Common Stock in which such a conversion occurs, then from and after the date upon which such outstanding shares are so converted, redeemed or
retired, “Preferred Stock” shall mean such Common Stock; provided that upon the closing of the sale or issuance by the Company of its next round of preferred stock (“Next Round Stock”), which occurs after the Effective Date but
prior to the date that the Company makes its first filing with the SEC for an Initial Public 

 Offering, to a bona fide investor in a transaction or series of related transactions in
which the Company receives aggregate gross proceeds of at least $5,000,000 (“Next Round”), at the option of the Warrantholder, the Preferred Stock shall be of the same class and series as the Next Round Stock. 

“Purchase Price” means, with respect to any exercise of this Agreement, an amount equal to the Exercise
Price as of the relevant time multiplied by the number of shares of Preferred Stock requested to be exercised under this Agreement pursuant to such exercise. 
 “Rights Agreement” means the Amended and Restated Investors Rights Agreement dated as of May 8, 2008, 2011, as amended. 

SECTION 2. TERM OF THE AGREEMENT. 
 Except as otherwise provided for herein, the term of this Agreement and the right to purchase Preferred Stock as granted herein (the “Warrant) shall commence on the Effective Date and shall be
exercisable for a period ending upon the earlier to occur of (i) ten (10) years from the Effective Date; (ii) five (5) years after the Initial Public Offering; or (iii) the consummation of a Merger Event in which the holders
of Preferred Stock receive cash or freely publicly tradeable securities in such transaction with an aggregate value per share of Preferred Stock which is greater than two times the Exercise Price (a “Terminating Merger”).

 SECTION 3. EXERCISE OF THE PURCHASE RIGHTS. 
 (a) Exercise. The purchase rights set forth in this Agreement are exercisable by the Warrantholder, in whole or in part, at any time, or from time to time, prior to the expiration of the term set
forth in Section 2, by tendering to the Company at its principal office a notice of exercise in the form attached hereto as Exhibit I (the “Notice of Exercise”), duly completed and executed. Promptly upon receipt of the
Notice of Exercise and the payment of the Purchase Price in accordance with the terms set forth below, and in no event later than three (3) days thereafter, the Company shall issue to the Warrantholder a certificate for the number of shares of
Preferred Stock purchased and shall execute the acknowledgment of exercise in the form attached hereto as Exhibit II (the “Acknowledgment of Exercise”) indicating the number of shares which remain subject to future purchases,
if any. 
 The Purchase Price may be paid at the Warrantholder’s election either (i) by cash or check, or (ii) by
surrender of all or a portion of this Agreement for shares of Preferred Stock to be exercised under this Agreement and, if applicable, an amended Agreement representing the remaining number of shares purchasable hereunder, as determined below
(“Net Issuance”). If the Warrantholder elects the Net Issuance method, the Company will issue Preferred Stock in accordance with the following formula: 
 X = Y(A-B) 

             A 

 

					
	Where:	  	X =	    	the number of shares of Preferred Stock to be issued to the Warrantholder.
			
		  	Y =	    	the number of shares of Preferred Stock requested to be exercised under this Agreement.

					
		  	A =	    	the fair market value of one (1) share of Preferred Stock at the time of
		  		    	issuance of such shares of Preferred Stock.
			
		  	B =	    	the Exercise Price.

 For purposes of the above calculation, current fair market value of Preferred Stock shall mean with
respect to each share of Preferred Stock: 
 (i) if the exercise is in connection with an Initial Public
Offering, and if the Company’s Registration Statement relating to such Initial Public Offering has been declared effective by the SEC, then the fair market value per share shall be the product of (x) the initial “Price to Public”
of the Common Stock specified in the final prospectus with respect to the offering and (y) the number of shares of Common Stock into which each share of Preferred Stock is convertible at the time of such exercise; 

(ii) if the exercise is after, and not in connection with an Initial Public Offering, and: 

(A) if the Common Stock is traded on a securities exchange, the fair market value shall be deemed to be the product of
(x) the average of the closing prices over a five (5) day period ending three days before the day the current fair market value of the securities is being determined and (y) the number of shares of Common Stock into which each share
of Preferred Stock is convertible at the time of such exercise; or 
 (B) if the Common Stock is traded
over-the-counter, the fair market value shall be deemed to be the product of (x) the average of the closing bid and asked prices quoted on the NASDAQ system (or similar system) over the five (5) day period ending three days before the day
the current fair market value of the securities is being determined and (y) the number of shares of Common Stock into which each share of Preferred Stock is convertible at the time of such exercise; 

(iii) if at any time the Common Stock is not listed on any securities exchange or quoted in the NASDAQ National Market or
the over-the-counter market, the current fair market value of Preferred Stock shall be the product of (x) the highest price per share which the Company could obtain from a willing buyer (not a current employee or director) for shares of Common
Stock sold by the Company, from authorized but unissued shares, as determined in good faith by its Board of Directors and (y) the number of shares of Common Stock into which each share of Preferred Stock is convertible at the time of such
exercise, unless the Company shall become subject to a Merger Event, in which case the fair market value of Preferred Stock shall be deemed to be the per share value received by the holders of the Company’s Preferred Stock on a common
equivalent basis pursuant to such Merger Event. 
 Upon partial exercise by either cash or Net Issuance, the Company shall
promptly issue an amended Agreement representing the remaining number of shares purchasable hereunder. All other terms and conditions of such amended Agreement shall be identical to those contained herein, including, but not limited to the Effective
Date hereof. 

 (b) Exercise Prior to Expiration. To the extent this Agreement is not previously
exercised as to all Preferred Stock that the holder has a right to exercise as of the date of the expiration of this Warrant, and if the fair market value of one share of the Preferred Stock is greater than the Exercise Price then in effect, this
Agreement shall be deemed automatically exercised pursuant to Section 3(a) (even if not surrendered) immediately before its expiration for all remaining shares of Preferred Stock that are entitled to be exercised as of the date of expiration.
For purposes of such automatic exercise, the fair market value of one share of the Preferred Stock upon such expiration shall be determined pursuant to Section 3(a). To the extent this Agreement or any portion thereof is deemed automatically
exercised pursuant to this Section 3(b), the Company agrees to promptly notify the Warrantholder of the number of shares of Preferred Stock, if any, the Warrantholder is to receive by reason of such automatic exercise. 

SECTION 4. RESERVATION OF SHARES. 
 During the term of this Agreement, the Company will at all times have authorized and reserved a sufficient number of shares of its Series D Preferred Stock or Next Round Stock, if issued, to provide for
the exercise of the rights to purchase Series D Preferred Stock, or Next Round Stock, if issued, as provided for herein, and shall have authorized and reserved a sufficient number of shares of its Common Stock to provide for the conversion of the
shares of Series D Preferred Stock or Next Round Stock, if issued, available hereunder. 
 SECTION 5. NO FRACTIONAL
SHARES OR SCRIP. 
 No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Agreement, but in lieu of such fractional shares the Company shall make a cash payment therefor upon the basis of the Exercise Price then in effect. 
 SECTION 6. NO RIGHTS AS SHAREHOLDER/STOCKHOLDER. 
 This Agreement does not
entitle the Warrantholder to any voting rights or other rights as a shareholder/stockholder of the Company prior to the exercise of this Agreement. 
 SECTION 7. WARRANTHOLDER REGISTRY. 
 The Company shall maintain a registry
showing the name and address of the registered holder of this Agreement. Warrantholder’s initial address, for purposes of such registry, is set forth in Section 12(g) below. Warrantholder may change such address by giving written notice of
such changed address to the Company. 
 SECTION 8. ADJUSTMENT RIGHTS. 

The Exercise Price and the number of shares of Preferred Stock purchasable hereunder are subject to adjustment, as follows: 

(a) Merger Event. The Company shall give Warrantholder written notice at least twenty (20) days prior to the closing of any
proposed Merger Event. If at any time there shall be a Merger Event (other than a Terminating Merger), then, upon the closing thereof, the successor or surviving entity shall assume the obligations of this Agreement and lawful provision shall be
made so that the Warrantholder shall thereafter be entitled to receive, upon exercise of this Agreement, the number of shares of capital stock or other securities or property of the successor corporation resulting from such Merger Event that would
have been issuable if 

 
Warrantholder had exercised this Agreement immediately prior to such Merger Event. In any such case, appropriate adjustment (as determined in good faith by the Company’s Board of Directors)
shall be made in the application of the provisions of this Agreement with respect to the rights and interests of the Warrantholder after such Merger Event to the end that the provisions of this Agreement (including adjustments of the Exercise Price
and number of shares of Preferred Stock purchasable) shall be applicable in their entirety, and to the greatest extent possible. In connection with any Merger Event and upon Warrantholder’s written election to the Company, the Company shall
cause this Agreement to be exchanged for the consideration that Warrantholder would have received if Warrantholder chose to exercise its right to have shares issued pursuant to the Net Issuance provisions of this Agreement without actually
exercising such right, acquiring such shares and exchanging such shares for such consideration. 
 (b) Reclassification of
Shares. Except as set forth in Section 8(a), if the Company at any time after the date of this Agreement shall, by combination, reclassification, exchange or subdivision of securities or otherwise, change any of the securities as to which
purchase rights under this Agreement exist into the same or a different number of securities of any other class or classes, this Agreement shall thereafter represent the right to acquire such number and kind of securities as would have been issuable
as the result of such change with respect to the securities which were subject to the purchase rights under this Agreement immediately prior to such combination, reclassification, exchange, subdivision or other change. 

(c) Subdivision or Combination of Shares. If the Company at any time after the date of this Agreement shall combine or subdivide
its Preferred Stock, (i) in the case of a subdivision, the Exercise Price shall be proportionately decreased, and the number of shares of Preferred Stock issuable upon exercise of this Agreement shall be proportionately increased, or
(ii) in the case of a combination, the Exercise Price shall be proportionately increased, and the number of shares of Preferred Stock issuable upon the exercise of this Agreement shall be proportionately decreased. 

(d) Stock Dividends. If the Company at any time while this Agreement is outstanding and unexpired shall: 

(i) pay a dividend with respect to the Preferred Stock payable in Preferred Stock, then the Exercise Price shall be
adjusted, from and after the date of determination of stockholders entitled to receive such dividend or distribution, to that price determined by multiplying the Exercise Price in effect immediately prior to such date of determination by a fraction
(A) the numerator of which shall be the total number of shares of Preferred Stock outstanding immediately prior to such dividend or distribution, and (B) the denominator of which shall be the total number of shares of Preferred Stock
outstanding immediately after such dividend or distribution; or 
 (ii) make any other distribution with respect
to Preferred Stock (or stock into which the Preferred Stock is convertible), except any distribution specifically provided for in any other clause of this Section 8, then, in each such case, provision shall be made by the Company such that the
Warrantholder shall receive upon exercise or conversion of this Agreement a proportionate share of any such distribution as though it were the holder of the Preferred Stock (or other stock for which the Preferred Stock is convertible) as of the
record date fixed for the determination of the stockholders of the Company entitled to receive such distribution. 

 (e) Antidilution Rights. Additional antidilution rights applicable to the Preferred
Stock purchasable hereunder are as set forth in the Company’s Charter and shall be applicable with respect to the Preferred Stock issuable hereunder. The Company shall promptly provide the Warrantholder with any restatement, amendment,
modification or waiver of the Charter; provided, that no such amendment, modification or waiver shall impair or reduce the antidilution rights applicable to the Preferred Stock as of the date hereof unless such amendment, modification or
waiver affects the rights of Warrantholder with respect to the Preferred Stock in the same manner as it affects all other holders of Preferred Stock. The Company shall provide Warrantholder with prior written notice of any issuance of its stock or
other equity security to occur after the Effective Date of this Agreement if the issuance of such stock would result in an anti-dilution adjustment to the Preferred Stock under the Company Charter, which notice shall include (a) the price at
which such stock or security is to be sold, (b) the number of shares to be issued, and (c) such other information as necessary for Warrantholder to determine if a dilutive event has occurred. For the avoidance of doubt, there shall be no
duplicate anti-dilution adjustment pursuant to this subsection (e), the forgoing subsection (d) and the Company’s Charter. 
 (f) Notice of Adjustments. If: (i) the Company shall declare any dividend or distribution upon its stock, whether in stock, cash, property or other securities (assuming Warrantholder consents
to a dividend involving cash, property or other securities); (ii) the Company shall offer for subscription prorata to the holders of any class of its Preferred Stock or other convertible stock any additional shares of stock of any class or
other rights; (iii) there shall be any Merger Event; (iv) there shall be an Initial Public Offering; (v) the Company shall sell, lease, license or otherwise transfer all or substantially all of its assets; or (vi) there shall be
any voluntary dissolution, liquidation or winding up of the Company; then, in connection with each such event, the Company shall send to the Warrantholder: (A) at least twenty (20) days’ prior written notice of the date on which the
books of the Company shall close or a record shall be taken for such dividend, distribution, subscription rights (specifying the date on which the holders of Preferred Stock shall be entitled thereto) or for determining rights to vote in respect of
such Merger Event, dissolution, liquidation or winding up; (B) in the case of any such Merger Event, sale, lease, license or other transfer of all or substantially all assets, dissolution, liquidation or winding up, at least twenty
(20) days’ prior written notice of the date when the same shall take place (and specifying the date on which the holders of Preferred Stock shall be entitled to exchange their Preferred Stock for securities or other property deliverable
upon such Merger Event, dissolution, liquidation or winding up); and (C) in the case of an Initial Public Offering, the Company shall give the Warrantholder at least twenty (20) days’ written notice prior to the effective date
thereof. 
 Each such written notice shall set forth, in reasonable detail, (i) the event requiring the notice, and
(ii) if any adjustment is required to be made, (A) the amount of such adjustment, (B) the method by which such adjustment was calculated, (C) the adjusted Exercise Price (if the Exercise Price has been adjusted), and (D) the
number of shares subject to purchase hereunder after giving effect to such adjustment, and shall be given by first class mail, postage prepaid, or by reputable overnight courier with all charges prepaid, addressed to the Warrantholder at the address
for Warrantholder set forth in the registry referred to in Section 7. 
 (g) Timely Notice. Failure to timely
provide such notice required by subsection (f) above shall entitle Warrantholder to retain the benefit of the applicable notice period notwithstanding anything to the contrary contained in any insufficient notice received by Warrantholder. For
purposes of this subsection (g), and notwithstanding anything to the contrary in Section 12(g), the notice period shall begin on the date Warrantholder actually receives a written notice containing all the information required to be provided in
such subsection (f). , 

 SECTION 9. REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE COMPANY. 

(a) Reservation of Preferred Stock. The Series D Preferred Stock or Next Round Stock, if issued, issuable upon exercise of the
Warrantholder’s rights has been duly and validly reserved and, when issued in accordance with the provisions of this Agreement, will be validly issued, fully paid and non-assessable, and will be free of any taxes, liens, charges or encumbrances
of any nature whatsoever; provided, that the Series D Preferred Stock or Next Round Stock, if issued, issuable pursuant to this Agreement may be subject to restrictions on transfer under state and/or federal securities laws. The Company has
made available to the Warrantholder true, correct and complete copies of its Charter and current bylaws. The issuance of certificates for shares of Preferred Stock upon exercise of this Agreement shall be made without charge to the Warrantholder for
any issuance tax in respect thereof, or other cost incurred by the Company in connection with such exercise and the related issuance of shares of Preferred Stock; provided, that the Company shall not be required to pay any tax which may be
payable in respect of any transfer and the issuance and delivery of any certificate in a name other than that of the Warrantholder. 
 (b) Due Authority. The execution and delivery by the Company of this Agreement and the performance of all obligations of the Company hereunder, including the issuance to Warrantholder of the right
to acquire the shares of Preferred Stock and the Common Stock into which it may be converted, have been duly authorized by all necessary corporate action on the part of the Company. This Agreement: (1) does not violate the Company’s
Charter or current bylaws; (2) does not contravene any law or governmental rule, regulation or order applicable to it; and (3) does not and will not contravene any provision of, or constitute a default under, any indenture, mortgage,
contract or other instrument to which it is a party or by which it is bound. This Agreement constitutes a legal, valid and binding agreement of the Company, enforceable in accordance with its terms. 

(c) Consents and Approvals. No consent or approval of, giving of notice to, registration with, or taking of any other action in
respect of any state, federal or other governmental authority or agency is required with respect to the execution, delivery and performance by the Company of its obligations under this Agreement, except for the filing of notices pursuant to
Regulation D under the Act and any filing required by applicable state securities law, which filings will be effective by the time required thereby. 
 (d) Issued Securities. All issued and outstanding shares of Common Stock, Preferred Stock or any other securities of the Company have been duly authorized and validly issued and are fully paid and
nonassessable. All outstanding shares of Common Stock, Preferred Stock and any other securities were issued in full compliance with all federal and state securities laws. In addition, as of the date immediately preceding the date of this Agreement:

 (i) The authorized capital of the Company consists of (A) 77,200,000 shares of Common Stock, of which
20,434,500 shares are issued and outstanding, (B) 10,699,533 shares of Series A Preferred Stock, of which 10,699,533 shares are issued and outstanding and are convertible into 10,699,533 shares of Common Stock, (C) 16,442,307 shares of
Series B Preferred Stock, of which 16,442,307 shares are issued and outstanding and are convertible into 

 16,442,307 shares of Common Stock, (D) 10,030,761 shares of Series C Preferred Stock,
of which 10,030,761 shares are issued and outstanding and are convertible into 10,030,761 shares of Common Stock, and (E) 5,725,000 shares of Series D Preferred Stock, of which 5,311,743 shares are issued and outstanding and are convertible
into 5,311,743 shares of Common Stock. 
 (ii) The Company has reserved 12,094,843 shares of Common Stock for
issuance under its Stock Option Plan(s), under which 8,254,474 options are outstanding. There are no other options, warrants, conversion privileges or other rights presently outstanding to purchase or otherwise acquire any authorized but unissued
shares of the Company’s capital stock or other securities of the Company other than the warrant issued to AKA Search LLC for 133,940 shares of Common Stock, dated February 14, 2011. The Company has no outstanding loans to any employee,
officer or director of the Company, and the Company agrees not to enter into any such loan or otherwise guarantee the payment of any loan made to an employee, officer or director by a third party. 

(iii) Except as set forth in the Rights Agreement, in accordance with the Company’s Charter, no stockholder of the
Company has preemptive rights to purchase new issuances of the Company’s capital stock. 
 (e) Other Commitments to
Register Securities. Except as set forth in this Agreement and the Rights Agreement, the Company is not, pursuant to the terms of any other agreement currently in existence, under any obligation to register under the Act any of its presently
outstanding securities or any of its securities which may hereafter be issued. 
 (f) Exempt Transaction. Subject to the
accuracy of the Warrantholder’s representations in Section 10, the issuance of the Preferred Stock upon exercise of this Agreement, and the issuance of the Common Stock upon conversion of the Preferred Stock, will each constitute a
transaction exempt from (i) the registration requirements of Section 5 of the Act, in reliance upon Section 4(2) thereof, and (ii) the qualification requirements of the applicable state securities laws. 

(g) Compliance with Rule 144. If the Warrantholder proposes to sell Preferred Stock issuable upon the exercise of this Agreement,
or the Common Stock into which it is convertible, in compliance with Rule 144 promulgated by the SEC, then, if the Company is then a reporting company under the Act, upon Warrantholder’s written request to the Company, the Company shall furnish
to the Warrantholder, within ten days after receipt of such request, a written statement setting forth whether the Company is in compliance with the filing requirements of the SEC as required by Rule 144, as such Rule 144 may be amended from time to
time. 
 (h) Information Rights. Subject to limitations imposed by applicable securities laws, during the term of this
Warrant, Warrantholder shall be entitled to the information rights (a) afforded to other shareholders, (b) within 150 days after the end of each fiscal year, the consolidated and consolidating balance sheets of the Company and its
Subsidiaries as at the end of such fiscal year and the related consolidated (and with respect to statements of income, consolidating) statements of income, stockholders’ equity and cash flows of the Company and its Subsidiaries for such fiscal
year, certified by an independent public accountant of the Company as required under Section 7.1(c) of the Loan Agreement, (c) those information rights set forth in the Rights Agreement granted Significant Holders (as defined in the Rights
Agreement) to the 

 
extent not terminated; (d) within 60 days after the end of each quarter of each fiscal year, the balance sheets of the Company as at the end of such quarter and the related (and with respect
to statements of income) statements of income, stockholders’ equity and cash flows of the Company for such quarter and for the period from the beginning of the then current fiscal year to the end of such quarter; and (e) within 30 days
after the end of each quarter of each fiscal year, a capitalization table. 
 SECTION 10. REPRESENTATIONS AND COVENANTS
OF THE WARRANTHOLDER. 
 This Agreement has been entered into by the Company in reliance upon the following representations and
covenants of the Warrantholder: 
 (a) Investment Purpose. The right to acquire Preferred Stock or the Preferred Stock
issuable upon exercise of the Warrantholder’s rights contained herein will be acquired for investment and not with a view to the sale or distribution of any part thereof, and the Warrantholder has no present intention of selling or engaging in
any public distribution of the same except pursuant to a registration or exemption. 
 (b) Private Issue. The
Warrantholder understands (i) that the Preferred Stock issuable upon exercise of this Agreement is not registered under the Act or qualified under applicable state securities laws on the ground that the issuance contemplated by this Agreement
will be exempt from the registration and qualifications requirements thereof, and (ii) that the Company’s reliance on such exemption is predicated on the representations set forth in this Section 10. 

(c) Disposition of Warrantholder’s Rights. In no event will the Warrantholder make a disposition of any of its
(a) rights to acquire Preferred Stock under this Agreement, or (b) the Preferred Stock issuable upon exercise of such rights, unless and until (i) it shall have notified the Company of the proposed disposition, and (ii) if
requested by the Company, it shall have furnished the Company with an opinion of counsel (which may be an opinion of inhouse counsel) reasonably satisfactory to the Company to the effect that (A) appropriate action necessary for compliance with
the 33 Act has been taken, or (B) an exemption from the registration requirements of the 33 Act is available. The foregoing notice provisions shall expire as to any particular share of Preferred Stock when (1) such security shall have been
effectively registered under the 33 Act and sold by the holder thereof in accordance with such registration or (2) such security shall have been sold without registration in compliance with Rule 144 under the 33 Act, or (3) a letter shall
have been issued to the Warrantholder at its request by the staff of the SEC or a ruling shall have been issued to the Warrantholder at its request by the SEC stating that no action shall be recommended by the SEC or taken by the SEC, as the case
may be, if such security is transferred without registration under the 33 Act in accordance with the conditions set forth in such letter or ruling and such letter or ruling specifies that no subsequent restrictions on transfer are required. Whenever
the restrictions imposed hereunder shall terminate, as hereinabove provided, the Warrantholder or holder of a share of Preferred Stock then outstanding as to which such restrictions have terminated shall be entitled to receive from the Company,
without expense to such holder, one or more new certificates for this Agreement or for such shares of Preferred Stock not bearing any restrictive legend. 
 (d) Financial Risk. The Warrantholder has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of its investment, and has the ability
to bear the economic risks of its investment. 

 (e) Risk of No Registration. The Warrantholder understands that if the Company does
not register with the SEC pursuant to Section 12 of the Securities Exchange Act of 1934 (the “1934 Act”), or file reports pursuant to Section 15(d) of the 1934 Act, or if a registration statement covering the securities
under the Act is not in effect when it desires to sell (1) the rights to purchase Preferred Stock pursuant to this Agreement or (ii) the Preferred Stock issuable upon exercise of the right to purchase, it may be required to hold such
securities for an indefinite period. The Warrantholder also understands that any sale of (A) its rights hereunder to purchase Preferred Stock or (B) Preferred Stock issued or issuable hereunder which might be made by it in reliance upon
Rule 144 under the Act may be made only in accordance with the terms and conditions of that Rule. 
 (f) Accredited Investor.
Warrantholder is an “accredited investor” within the meaning of the Securities and Exchange Rule 501 of Regulation D, as presently in effect. 
 (g) Legends. The Warrantholder understands that the share certificate(s) evidencing the shares issued hereunder shall be endorsed with legend(s) substantially similar to the following: 

THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE
SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL (WHICH MAY BE INHOUSE COUNSEL) REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT
REQUIRED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS. 
 Any legend required by any
applicable state securities laws. 
 (h) The Warrantholder hereby agrees that it will not, without the prior written consent of
the managing underwriter, during the period commencing on the date of the final prospectus relating to the Company’s Initial Public Offering and ending on the date specified by the Company and the managing underwriter (such period not to exceed
one hundred and eighty (180) days) following the effective date of the registration statement for such offering, if so required by the underwriters of such offering, (i) lend, offer, pledge, sell, contract to sell, sell any option or
contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable
or exchangeable for Common Stock (whether such shares or any such securities are then owned by the Warrantholder or are thereafter acquired), or (ii) enter into any swap, hedging or other arrangement that transfers to another, in whole or in
part, any of the economic consequences of ownership of the Common Stock, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise. The
foregoing provisions of this Section 10(h) shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, and shall only be applicable to the Warrantholder if all officers, directors and one percent
(1%) or more stockholders of the Company enter into similar agreements. The underwriters in connection with the Company’s Initial Public Offering are intended third party beneficiaries of this Section 10(h) and shall have the right,
power and authority to enforce the provisions hereof as though they were a party hereto. In order to enforce 

 
the foregoing covenant, the Company may impose stop-transfer instructions with respect to the Warrant Shares (or any securities into which such Warrant Shares are convertible) (and the shares or
securities of every other person subject to the foregoing restriction) until the end of such period. 
 SECTION 11.
TRANSFERS. 
 Subject to compliance with applicable federal and state securities laws, this Agreement and all rights
hereunder are transferable, in whole or in part, without charge to the holder hereof (except for transfer taxes) upon surrender of this Agreement properly endorsed. Each taker and holder of this Agreement, by taking or holding the same, consents and
agrees that this Agreement, when endorsed in blank, shall be deemed negotiable, and that the holder hereof, when this Agreement shall have been so endorsed and its transfer recorded on the Company’s books, shall be treated by the Company and
all other persons dealing with this Agreement as the absolute owner hereof for any purpose and as the person entitled to exercise the rights represented by this Agreement. The transfer of this Agreement shall be recorded on the books of the Company
upon receipt by the Company of a notice of transfer in the form attached hereto as Exhibit III (the “Transfer Notice”), at its principal offices and the payment to the Company of all transfer taxes and other governmental charges
imposed on such transfer. Until the Company receives such Transfer Notice, the Company may treat the registered owner hereof as the owner for all purposes. 
 SECTION 12. MISCELLANEOUS. 
 (a) Effective Date. The provisions of
this Agreement shall be construed and shall be given effect in all respects as if it had been executed and delivered by the Company on the date hereof. This Agreement shall be binding upon any successors or assigns of the Company. 

(b) Remedies. In the event of any default hereunder, the non-defaulting party may proceed to protect and enforce its rights either
by suit in equity and/or by action at law, including but not limited to an action for damages as a result of any such default, and/or an action for specific performance for any default where Warrantholder will not have an adequate remedy at law and
where damages will not be readily ascertainable. The Company expressly agrees that it shall not oppose an application by the Warrantholder or any other person entitled to the benefit of this Agreement requiring specific performance of any or all
provisions hereof or enjoining the Company from continuing to commit any such breach of this Agreement. 
 (c) No Impairment
of Rights. The Company will not, by amendment of its Charter or through any other means, avoid or seek to avoid the observance or performance of any of the terms of this Agreement, but will at all times in good faith assist in the carrying out
of all such terms and in the taking of all such actions as may be necessary or appropriate in order to protect the rights of the Warrantholder against impairment. 
 (d) Additional Documents. The Company, upon execution of this Agreement, shall provide the Warrantholder with certified resolutions with respect to the representations, warranties and covenants set
forth in Sections 9(a) through 9(d), 9(f) and 9(g). The Company shall also supply such other documents as the Warrantholder may from time to time reasonably request. 

 (e) Attorney’s Fees. In any litigation, arbitration or court proceeding between
the Company and the Warrantholder relating hereto, the prevailing party shall be entitled to attorneys’ fees and expenses and all costs of proceedings incurred in enforcing this Agreement. For the purposes of this Section 12(e),
attorneys’ fees shall include without limitation fees incurred in connection with the following: (i) contempt proceedings; (ii) discovery; (iii) any motion, proceeding or other activity of any kind in connection with an
insolvency proceeding; (iv) garnishment, levy, and debtor and third party examinations; and (v) post judgment motions and proceedings of any kind, including without limitation any activity taken to collect or enforce any judgment.

 (f) Severability. In the event any one or more of the provisions of this Agreement shall for any reason be held
invalid, illegal or unenforceable, the remaining provisions of this Agreement shall be unimpaired, and the invalid, illegal or unenforceable provision shall be replaced by a mutually acceptable valid, legal and enforceable provision, which comes
closest to the intention of the parties underlying the invalid, illegal or unenforceable provision. 
 (g) Notices.
Except as otherwise provided herein, any notice, demand, request, consent, approval, declaration, service of process or other communication that is required, contemplated, or permitted under this Agreement or with respect to the subject matter
hereof shall be in writing, and shall be deemed to have been validly served, given, delivered, and received upon the earlier of: (i) the day of transmission by facsimile or hand delivery if transmission or delivery occurs on a business day at
or before 5:00 pm in the time zone of the recipient, or, if transmission or delivery occurs on a non-business day or after such time, the first business day thereafter, or the first business day after deposit with an overnight express service or
overnight mail delivery service; or (ii) the third calendar day after deposit in the United States mails, with proper first class postage prepaid, and shall be addressed to the party to be notified as follows: 

If to Warrantholder: 
 HERCULES TECHNOLOGY GROWTH CAPITAL, INC. 
 Legal Department 

Attention: Chief Legal Officer and Manuel Henriquez 
 400 Hamilton Avenue, Suite 310 
 Palo Alto, CA 94301 

Facsimile: 650-473-9194 
 Telephone: 650-289-3060 
  

	 	(i)	If to the Company: 

 TRULIA,
INC. 
 Attention: Chief Executive Officer 
 116 New Montgomery Street, Suite 300 
 San Francisco, CA 94105 

Facsimile: (415) 983-2429 
 Telephone: (415) 648-4358 
 or to such other address as each party may designate for itself
by like notice. 
 (h) Entire Agreement; Amendments. This Agreement constitute the entire agreement and understanding of
the parties hereto in respect of the subject matter hereof, and 

 
supersede and replace in their entirety any prior proposals, term sheets, letters, negotiations or other documents or agreements, whether written or oral, with respect to the subject matter
hereof (including Warrantholder’s proposal letter dated August 2, 2011). None of the terms of this Agreement may be amended except by an instrument executed by each of the parties hereto. 

(i) Headings. The various headings in this Agreement are inserted for convenience only and shall not affect the meaning or
interpretation of this Agreement or any provisions hereof. 
 (j) Advice of Counsel. Each of the parties represents to
each other party hereto that it has discussed (or had an opportunity to discuss) with its counsel this Agreement and, specifically, the provisions of Sections 12(n), 12(o), 12(p). 12(q) and 12(r). 

(k) No Strict Construction. The parties hereto have participated jointly in the negotiation and drafting of this Agreement. In the
event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties hereto and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the
authorship of any provisions of this Agreement. 
 (l) No Waiver. No omission or delay by Warrantholder at any time to
enforce any right or remedy reserved to it, or to require performance of any of the terms, covenants or provisions hereof by the Company at any time designated, shall be a waiver of any such right or remedy to which Warrantholder is entitled, nor
shall it in any way affect the right of Warrantholder to enforce such provisions thereafter. 
 (m) Survival. All
representations and warranties contained in this Agreement or in any document delivered pursuant hereto shall be for the benefit of Warrantholder and shall survive the execution and delivery of this Agreement and the expiration or other termination
of this Agreement. 
 (n) Governing Law. This Agreement have been negotiated and delivered to Warrantholder in the State
of California, and shall have been accepted by Warrantholder in the State of California. Delivery of Preferred Stock to Warrantholder by the Company under this Agreement is due in the State of California. This Agreement shall be governed by, and
construed and enforced in accordance with, the laws of the State of California, excluding conflict of laws principles that would cause the application of laws of any other jurisdiction. 

(o) Consent to Jurisdiction and Venue. All judicial proceedings arising in or under or related to this Agreement may be brought in
any state or federal court of competent jurisdiction located in the State of California. By execution and delivery of this Agreement, each party hereto generally and unconditionally: (a) consents to personal jurisdiction in Santa Clara County,
State of California; (b) waives any objection as to jurisdiction or venue in Santa Clara County, State of California; (c) agrees not to assert any defense based on lack of jurisdiction or venue in the aforesaid courts; and
(d) irrevocably agrees to be bound by any judgment rendered thereby in connection with this Agreement. Service of process on any party hereto in any action arising out of or relating to this Agreement shall be effective if given in accordance
with the requirements for notice set forth in Section 12(g), and shall be deemed effective and received as set forth in Section 12(g). Nothing herein shall affect the right to serve process in any other manner permitted by law or shall
limit the right of either party to bring proceedings in the courts of any other jurisdiction. 

 (p) Mutual Waiver of Jury Trial. Because disputes arising in connection with complex
financial transactions are most quickly and economically resolved by an experienced and expert person and the parties wish applicable state and federal laws to apply (rather than arbitration rules), the parties desire that their disputes be resolved
by a judge applying such applicable laws. EACH OF THE COMPANY AND WARRANTHOLDER SPECIFICALLY WAIVES ANY RIGHT IT MAY HAVE TO TRIAL BY JURY OF ANY CAUSE OF ACTION, CLAIM, CROSS-CLAIM, COUNTERCLAIM, THIRD PARTY CLAIM OR ANY OTHER CLAIM (COLLECTIVELY,
“CLAIMS”) ASSERTED BY THE COMPANY AGAINST WARRANTHOLDER OR ITS ASSIGNEE OR BY WARRANTHOLDER OR ITS ASSIGNEE AGAINST THE COMPANY. This waiver extends to all such Claims, including Claims that involve Persons other than the Company and
Warrantholder; Claims that arise out of or are in any way connected to the relationship between the Company and Warrantholder; and any Claims for damages, breach of contract, specific performance, or any equitable or legal relief of any kind,
arising out of this Agreement. 
 (q) Arbitration. If the Mutual Waiver of Jury Trial set forth in Section 12(p) is
ineffective or unenforceable, the parties agree that all Claims shall be submitted to binding arbitration in accordance with the commercial arbitration rules of JAMS (the “Rules”), such arbitration to occur before one arbitrator, which
arbitrator shall be a retired California state judge or a retired Federal court judge. Such proceeding shall be conducted in San Francisco County, California, with California rules of evidence and discovery applicable to such arbitration. The
decision of the arbitrator shall be binding on the parties, and shall be final and nonappealable to the maximum extent permitted by law. Any judgement rendered by the arbitrator may be entered in a court of competent jurisdiction and enforced by the
prevailing party as a final judgment of such court. 
 (r) Prearbitration Relief. In the event Claims are to be resolved
by arbitration, either party may seek from a court of competent jurisdiction identified in Section 12(o), any prejudgment order, writ or other relief and have such prejudgment order, writ or other relief enforced to the fullest extent permitted
by law notwithstanding that all Claims are otherwise subject to resolution by binding arbitration. 
 (s) Counterparts.
This Agreement and any amendments, waivers, consents or supplements hereto may be executed in any number of counterparts, and by different parties hereto in separate counterparts, each of which when so delivered shall be deemed an original, but all
of which counterparts shall constitute but one and the same instrument. 
 (t) Specific Performance. The parties hereto
hereby declare that it is impossible to measure in money the damages which will accrue to Warrantholder by reason of the Company’s failure to perform any of the obligations under this Agreement and agree that the terms of this Agreement shall
be specifically enforceable by Warrrantholder. If Warrantholder institutes any action or proceeding to specifically enforce the provisions hereof, any person against whom such action or proceeding is brought hereby waives the claim or defense
therein that Warrantholder has an adequate remedy at law, and such person shall not offer in any such action or proceeding the claim or defense that such remedy at law exists. 
 [Remainder of Page Intentionally Left Blank] 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by
its officers thereunto duly authorized as of the Effective Date. 
  

							
	 COMPANY:
	 		 	TRULIA, INC,
				
		 		 	By:	 	 /s/ Peter Flint

		 		 	Title:	 	 CEO

		 		 	Notice Address: Ann:	 	  

		 		 		 	  

		 		 		 	  

		 		 	Facsimile: (_,)	 	  

  

							
	WARRANTHOLDER:	 	HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
				
		 		 	By:	 	  

		 		 	Name:	 	K. Nicholas Martitsch
		 		 	Its:	 	Associate General Counsel

 [Signature page to Warrant Agreement] 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by its
officers thereunto duly authorized as of the Effective Date. 
  

							
	 COMPANY:
	 		 	TRULIA, INC,
				
		 		 	By:	 	  

		 		 	Title:	 	  

		 		 	Notice Address: Ann:	 	  

		 		 		 	  

		 		 		 	  

		 		 	Facsimile: (_,)	 	  

  

							
	WARRANTHOLDER:	 	HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
				
		 		 	By:	 	 /s/ K. Nicholas Martitsch

		 		 	Name:	 	K. Nicholas Martitsch
		 		 	Its:	 	Associate General Counsel

 [Signature page to Warrant Agreement] 

 EXHIBIT I 
 NOTICE OF EXERCISE 
 To: 

 

	(1)	The undersigned Warrantholder hereby elects to purchase [                ] shares of the
Series              Preferred Stock of Trulia, Inc., pursuant to the terms of the Agreement dated the [    ] day of
[                ] (the “Agreement”) between
[                    ] and the Warrantholder, and [CASH PAYMENT: tenders herewith payment of the Purchase Price in full, together with all applicable
transfer taxes, if any.] [NET ISSUANCE: elects pursuant to Section 3(a) of the Agreement to effect a Net Issuance.] 

  

	(2)	Please issue a certificate or certificates representing said shares of Series [ ] Preferred Stock in the name of the undersigned or in such other name as is specified
below. 

  

			
		 	  

	 (Name)
	 	
		
		 	     

		 	(Address)

  

							
	WARRANTHOLDER:	 	HERCULES TECHNOLOGY GROWTH CAPITAL, INC.
				
		 		 	By:	 	  

		 		 	Name:	 	K. Nicholas Martitsch
		 		 	Its:	 	Associate General Counsel

 EXHIBIT II 
 ACKNOWLEDGMENT OF EXERCISE 
 The undersigned
[                             ], hereby acknowledge receipt of the “Notice of Exercise” from
Hercules Technology Growth Capital, Inc. to purchase [                ] shares of the Series
[                ] Preferred Stock of Trulia, Inc., pursuant to the terms of the Agreement, and further acknowledges that
[                ] shares remain subject to purchase under the terms of the Agreement. 
 COMPANY: 
  

			
	By:	 	  

	Title:	 	  

	Date:	 	  

 EXHIBIT III 
 TRANSFER NOTICE 
 (To transfer or assign the foregoing Agreement execute this form and supply
required information. Do not use this form to purchase shares.) 
 FOR VALUE RECEIVED, the foregoing Agreement and all rights evidenced thereby
are hereby transferred and assigned to 
  

					
	  
	 	
		 		 	(Please Print)

  

					
	whose address is	 	  
	 	
		
	  
	 	

  

			
		 	Dated:
                    

 

							
		 	Holder’s Signature:	 	  
	 	
				
		 	Holder’s Address:	 	  
	 	

  

					
	Signature Guaranteed:	 	  
	 	

 NOTE: The signature to this Transfer Notice must correspond with the name as it appears on the face of the Agreement,
without alteration or enlargement or any change whatever. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Agreement.<![CDATA[Third Amended & Restated Investor Rights Agreement]]>

 Exhibit 4.4 
 TRULIA, INC. 
 THIRD AMENDED AND RESTATED INVESTOR RIGHTS 

AGREEMENT 

May 8, 2008 

 TABLE OF CONTENTS 

 

					
	1. Registration Rights	  	 	2	  
		
	 1.1 Definitions
	  	 	2	  
		
	 1.2 Request for Registration
	  	 	3	  
		
	 1.3 Company Registration
	  	 	5	  
		
	 1.4 Form S-3 Registration
	  	 	6	  
		
	 1.5 Obligations of the Company
	  	 	7	  
		
	 1.6 Information from Holder
	  	 	9	  
		
	 1.7 Expenses of Registration
	  	 	9	  
		
	 1.8 Delay of Registration
	  	 	9	  
		
	 1.9 Indemnification
	  	 	10	  
		
	 1.10 Reports Under the 1934 Act
	  	 	12	  
		
	 1.11 Assignment of Registration Rights
	  	 	13	  
		
	 1.12 Limitations on Subsequent Registration Rights
	  	 	13	  
		
	 1.13 Market Stand-off Agreement
	  	 	13	  
		
	 1.14 Termination of Registration Rights
	  	 	14	  
		
	2. Covenants	  	 	14	  
		
	 2.1 Delivery of Financial Statements
	  	 	14	  
		
	 2.2 Inspection
	  	 	15	  
		
	 2.3 Right of First Offer
	  	 	16	  
		
	 2.4 IPO Participation Right
	  	 	18	  
		
	 2.5 Expenses
	  	 	18	  
		
	 2.6 Director and Officer Insurance
	  	 	19	  
		
	 2.7 Board Committees; Executive Compensation and Related Party Transactions
	  	 	19	  
		
	 2.8 Drag-Along Rights
	  	 	19	  
		
	 2.9 Reserved
	  	 	20	  
		
	 2.10 Termination of Covenants
	  	 	20	  
		
	3. Miscellaneous	  	 	21	  
		
	 3.1 Legend
	  	 	21	  

					
		
	 3.2 Successors and Assigns
	  	 	21	  
		
	 3.3 Governing Law
	  	 	21	  
		
	 3.4 Counterparts
	  	 	21	  
		
	 3.5 Titles and Subtitles
	  	 	21	  
		
	 3.6 Notices
	  	 	22	  
		
	 3.7 Entire Agreement; Amendments and Waivers
	  	 	22	  
		
	 3.8 Waiver
	  	 	23	  
		
	 3.9 Severability
	  	 	23	  
		
	 3.10 Aggregation of Stock
	  	 	23	  
		
	 3.11 Expenses
	  	 	23	  

  

			
	EXHIBIT A	  	Schedule of A Investors
		
	EXHIBIT B	  	Schedule of Series B Investors
		
	EXHIBIT C	  	Schedule of Series C Investors
		
	EXHIBIT D	  	Schedule of Series D Investors
		
	EXHIBIT E	  	Schedule of Common Holders

 TRULIA, INC. 
 THIRD AMENDED AND RESTATED INVESTOR RIGHTS 
 AGREEMENT 

This Third Amended and Restated Investor Rights Agreement (this “Agreement”) is made as of the 8th day of May,
2008, by and among Trulia, Inc., a Delaware corporation (the “Company”), and the holders of Series A Preferred Stock (the “Series A Preferred”) listed on Exhibit A (the “Series A
Investors”), the holders of Series B Preferred Stock (the “Series B Preferred”) listed on Exhibit B (the “Series B Investors”), the holders of Series C Preferred Stock (the
“Series C Preferred”) listed on Exhibit C (the “Series C Investors”), the holders of Series D Preferred Stock (the “Series D Preferred”) listed on Exhibit D (the
“Series D Investors,” and together with the Series A Investors, the Series B Investors and the Series C investors the “Investors”) and the holders of Common Stock listed on Exhibit E hereto (the
“Common Holders”). 
 RECITALS 

WHEREAS, the Company, the Series A Investors, the Series B Investors, the Series C Investors and the Common Holders have entered into a
Second Amended and Restated Investors Rights Agreement dated as of May 7, 2007 (the “Existing Investor Rights Agreement”) and desire to amend and restate the Existing Investor Rights Agreement in its entirety in
accordance with Section 3.7 thereof; 
 WHEREAS, the Company and the Series D Investors intend to execute a Series D
Preferred Stock Purchase Agreement of even date herewith (the “Purchase Agreement”), pursuant to which the Series D Investors intend to purchase and the Company intends to sell shares of the Company’s Series D Preferred
Stock (the “Series D Preferred”); 
 WHEREAS, the execution of this Agreement on or by the Closing (as
defined in the Purchase Agreement) is a condition of the Company’s and the Investors’ mutual obligations at the Closing under the Purchase Agreement; 
 WHEREAS, in order to induce the Company’s Series A Investors, Series B Investors, Series C Investors and the Common Holders to approve the issuance of the Series D Preferred and to induce the Series
D Investors to invest funds in the Company pursuant to the Purchase Agreement, the Company, the Series D Investors and the other parties thereto hereby agree that this Agreement shall govern the rights of the Investors and the Common Holders to
cause the Company to register shares of Common Stock issuable or issued to them, the governance of the Company’s Board of Director committees as set forth in Section 2.7 below and certain other matters as set forth herein; 

AGREEMENT 

 NOW, THEREFORE, in consideration of the premises and the mutual covenants herein contained,
and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows: 

1. Registration Rights 
 1.1 Definitions 
 For purposes of this Agreement: 

(a) The term “Act” means the Securities Act of 1933, as amended. 

(b) The term “Form S-3” means such form under the Act as in effect on the date hereof or any successor
registration form under the Act subsequently adopted by the SEC that permits inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC. 

(c) The term “Holder” means any person owning of record or having the right to acquire Registrable Securities or
any assignee of record thereof to whom registration rights are assigned in accordance with Section 1.11 hereof, provided, however, that the Common Holders shall not be deemed to be Holders for the purposes of Sections 1.2, 1.4,
1.12, 2 or 3.7 of this Agreement. 
 (d) The term “1934 Act” means the Securities Exchange Act of 1934,
as amended. 
 (e) The term “register,” “registered” and
“registration” refer to a registration effected by preparing and filing a registration statement or similar document in compliance with the Act, and the declaration or ordering of effectiveness of such registration statement
or document. 
 (f) The term “Registrable Securities” means (i) the Common Stock issuable or issued
upon conversion of the Series A Preferred, Series B Preferred, Series C Preferred or Series D Preferred, (ii) shares of Common Stock purchased by the Holders pursuant to that certain Founder Common Stock Sale Agreement dated May 7, 2007,
(iii) any shares of Common Stock held by the Common Holders as of the date hereof or which may hereafter be acquired by the Common Holders from the Company, and (iv) any Common Stock of the Company issued as (or issuable upon the
conversion or exercise of any warrant, right or other security that is issued as) a dividend or other distribution with respect to, or in exchange for, or in replacement of, the shares referenced in (i), (ii) or (iii) above,
provided, however, that the foregoing definition shall exclude in all cases any Registrable Securities sold by a person in a transaction in which his, her or its rights under this Agreement are not assigned, and provided,
further, that the shares of Common Stock referenced in (iii) above (including shares issued as a dividend or other distribution with respect thereto) shall not be deemed Registrable Securities for the purposes of Sections 1.2, 1.4, 1.12,
2 and 3.7 of this Agreement. In addition, Common Stock or other 

  
 -2-

 
securities shall only be treated as Registrable Securities if and so long as they have not been (A) sold to or through a broker or dealer or underwriter in a public distribution or a public
securities transaction, including sales made pursuant to Rule 144 promulgated under the Act, or (B) sold in a transaction exempt from the registration and prospectus delivery requirements of the Act under Section 4(1) thereof so that all
transfer restrictions, and restrictive legends with respect thereto, if any, are removed upon the consummation of such sale. The number of shares of Registrable Securities deemed to be outstanding at any given time shall be the sum of the number of
shares of Common Stock outstanding that are Registrable Securities plus the number of shares of Common Stock issuable upon conversion of Preferred Stock or pursuant to then exercisable or convertible securities that are Registrable Securities
hereunder. 
 (g) The term “SEC” shall mean the Securities and Exchange Commission. 

1.2 Request for Registration 
 (a) Subject to the conditions of this Section 1.2, if the Company shall receive at any time after the earlier of (i) five (5) years after the date of this Agreement or (ii) six months
after the effective date of the Initial Offering, a written request (the “Initial Request”) from the Holders of twenty percent (20%) or more of the Registrable Securities then outstanding or a lesser percentage if
requesting registration of Registrable Securities with an anticipated aggregate offering price of at least $10,000,000 (the “Initiating Holders”), then the Company shall, within ten (10) days of the receipt of the
Initial Request, give written notice of the Initial Request to all Holders, and subject to the limitations of this Section 1.2, use its commercially reasonable best efforts to file, within forty-five days, a registration statement under the Act
covering the Registrable Securities that the Holders request to be registered in a written request received by the Company within twenty days of the mailing of the Company’s notice pursuant to this Section 1.2(a), and to use its
commercially reasonable best efforts to cause such registration statement to become effective within one hundred twenty days of the Initial Request. 
 (b) If the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made
pursuant to this Section 1.2 and the Company shall include such information in the written notice referred to in Section 1.2(a). In such event the right of any Holder to include its Registrable Securities in such registration shall be
conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting (unless otherwise mutually agreed by two-thirds (2/3) in interest of the Initiating
Holders and such Holder) to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall enter into an underwriting agreement in customary form with the underwriter or underwriters selected for
such underwriting by two-thirds (2/3) in interest of the Initiating Holders (which underwriter or underwriters shall be reasonably acceptable to the Company). Notwithstanding any other provision of this Section 1.2, if the underwriter
advises the Company in writing that marketing factors require a limitation of the number of securities underwritten (including Registrable Securities), then the Company shall so advise all Holders of Registrable Securities that would otherwise be
underwritten pursuant 

  
 -3-

 
hereto, and the number of shares that may be included in the underwriting shall be allocated to the Holders of such Registrable Securities on a pro rata basis based on the number of Registrable
Securities held by all such Holders (including the Initiating Holders) or otherwise agreed to by the Holders participating in such underwriting, provided however that the number of shares of Registrable Securities to be included in such underwriting
shall not be reduced unless all other securities are first entirely excluded from the underwriting and registration. Any Registrable Securities excluded or withdrawn from such underwriting shall be withdrawn from the registration. If Holders of more
than a majority of the Registrable Securities mutually requested for inclusion in the offering by the Initiating Holders are excluded from the offering pursuant to the foregoing mechanics, then such request for registration shall not count as one of
the two (2) permitted demand registrations under this Section 1.2. 
 (c) The Company shall not be required to effect
a registration pursuant to this Section 1.2: 
 (1) in any particular jurisdiction in which the Company would be required
to execute a general consent to service of process in effecting such registration, unless the Company is already subject to service in such jurisdiction and except as may be required under the Act; or 

(2) after the Company has effected two registrations pursuant to this Section 1.2, and such registrations have been declared or
ordered effective; or 
 (3) during the period starting with the date sixty days prior to the Company’s good faith
estimate of the date of the filing of, and ending on a date one hundred eighty days following the effective date of, a Company-initiated registration subject to Section 1.3 below, provided that the Company is actively employing in good faith
all reasonable efforts to cause such registration statement to become effective; or 
 (4) if the Initiating Holders propose to
dispose of Registrable Securities that may be registered on Form S-3 pursuant to Section 1.4 hereof; or 
 (5) if the
Company shall furnish to Holders requesting a registration statement pursuant to this Section 1.2, a certificate signed by the Company’s Chief Executive Officer or Chairman of the Board stating that in the good faith judgment of the Board
of Directors of the Company, it would be seriously detrimental to the Company and its stockholders for such registration statement to be effected at such time, in which event the Company shall have the right to defer such filing for a period of not
more than ninety (90) days after receipt of the request of the Initiating Holders, provided that such right to delay a request shall be exercised by the Company not more than once in any twelve-month period, provided, however, that the Company
shall not register any securities for the account of itself or any other stockholder during such ninety day period (other than a registration relating solely to the sale of securities of participants in a Company stock plan, a registration relating
to a corporate reorganization or transaction under Rule 145 of the Act, a registration on any form that does not include substantially the same information as would be required to be included in a registration statement

  
 -4-

 
covering the sale of the Registrable Securities, or a registration in which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being
registered). 
 1.3 Company Registration 
 (a) If the Company proposes to register (including for this purpose a registration initiated by the Company for stockholders other than the Holders) any of its stock or other securities under the Act in
connection with the public offering for cash of such securities (other than a registration relating solely to the sale of securities to participants in a Company stock plan, a registration relating to a corporate reorganization or other transaction
under Rule 145 of the Act, a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities, or a registration in
which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered), the Company shall, at such time, notify each Holder in writing at least forty-five (45) days prior to such
registration. Upon the written request of each Holder given within fifteen (15) days after delivery of such notice by the Company in accordance with Section 3.6, the Company shall, subject to the provisions of Section 1.3(c), cause to
be registered under the Act all of the Registrable Securities that each such Holder has requested to be registered. 
 Each
Holder’s written request shall state the number of Registrable Securities such Holder wishes to include in such registration statement. Holders that do not elect to participate in any registration and underwriting under this Section 1.3
shall nevertheless continue to have the right to include any Registrable Securities in subsequent registrations and underwritings to which this Section 1.3 is applicable. 
 (b) Right to Terminate Registration. The Company shall have the right to terminate or withdraw any registration initiated by it under this Section 1.3 prior to the effectiveness of such
registration whether or not any Holder has elected to include securities in such registration. The expenses of such withdrawn registration shall be borne by the Company in accordance with Section 1.7 hereof. 

(c) Underwriting Requirements. The Company shall not be required to include in any registration and underwriting to which
this Section 1.3 is applicable, the Registrable Securities of any Holder that fails to execute the underwriting agreement entered into between the Company and the underwriter or underwriters selected by it. In addition, the Company shall be
required to include in the offering only that number of Registrable Securities that the underwriters determine in good faith will not jeopardize the success of the offering (the securities so included to be apportioned pro rata first among the
selling Holders that are Investors and second among the selling Holders that are Common Holders, in each case according to the total amount of Registrable Securities entitled to be included therein by such group of selling Holders, but in no event
shall (i) the amount of securities of the selling Holders that are Investors, included in the offering be reduced below thirty percent (30%) of the total amount of securities 

  
 -5-

 
included in such offering, unless such offering is the initial public offering of the Company’s securities, in which case the selling Holders that are Investors, may be completely excluded
if the underwriters make the determination described above and no other stockholder’s securities are included, or (ii) the number of shares of Registrable Securities of the selling Holders that are Investors, to be included in such
underwriting, be reduced unless all other securities (other than those of the Company) are first entirely excluded from the underwriting. For purposes of the preceding parenthetical concerning apportionment, for any selling stockholder that is a
Holder of Registrable Securities and that is a venture capital fund, partnership, limited liability company or corporation, the affiliated venture capital funds, partners, retired partners, members and stockholders of such Holder, or the estates and
family members of any such partners, retired partners, members and any trusts for the benefit of any of the foregoing persons shall be deemed to be a single “selling Holder,” and any pro rata reduction with respect to such “selling
Holder” shall be based upon the aggregate amount of Registrable Securities owned of record by all such related entities and individuals. 
 (d) No Demand Registration. Registration pursuant to this Section 1.3 shall not be deemed to be a request for registration as described in Section 1.2 above. Except as otherwise
provided herein, there shall be no limit on the number of times the Holders may request registration of Registrable Securities under this Section 1.3. 
 1.4 Form S-3 Registration 
 In case the Company shall receive from
any Holder or the Holders a written request or requests that the Company effect a registration on Form S-3 and any related qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder or Holders, the
Company shall: 
 (a) promptly give written notice of the proposed registration, and any related qualification or compliance, to
all other Holders of Registrable Securities; and 
 (b) use its commercially reasonable best efforts to effect, as soon as
reasonably practicable, such registration and all such qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holders’ Registrable Securities as are
specified in such request, together with all or such portion of the Registrable Securities of any other Holders joining in such request as are specified in a written request given within fifteen (15) days after receipt of such written notice
from the Company, provided, however, that the Company shall not be obligated to effect any such registration, qualification or compliance, pursuant to this Section 1.4: 

(1) if Form S-3 is not available for use by the Company with respect to such offering by the Holders; 

(2) if the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose
to sell Registrable Securities and such other securities (if any) at an aggregate price to the public of not less than $1,000,000; 

  
 -6-

 (3) if the Company shall furnish to the Holders a certificate signed by the Chief Executive
Officer or Chairman of the Board of the Company stating that in the good faith judgment of the Board of Directors of the Company, it would be detrimental to the Company and its stockholders for such Form S-3 registration to be effected at such time,
in which event the Company shall have the right to defer the filing of the Form S-3 registration statement for a period of not more than ninety (90) days after receipt of the request of the Holder or Holders under this Section 1.4,
provided, however, that the Company shall not utilize this right more than once in any twelve (12) month period; provided further that the Company shall not register any securities for the account of itself or any other
stockholder during such ninety day period (other than a registration relating solely to the sale of securities of participants in a Company stock plan, a registration relating to a corporate reorganization or transaction under Rule 145 of the Act, a
registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities, or a registration in which the only Common Stock being
registered is Common Stock issuable upon conversion of debt securities that are also being registered); 
 (4) if the Company
has, within the twelve (12) month period preceding the date of such request, already effected one (1) registration on Form S-3 for the Holders pursuant to this Section 1.4; or 

(5) in any particular jurisdiction in which the Company would be required to qualify to do business or to execute a general consent to
service of process in effecting such registration, qualification or compliance not already so qualified or consented. 
 (c) If
the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to this Section 1.4 and the Company shall
include such information in the written notice referred to in Section 1.4(a). The provisions of Section 1.2(b) shall be applicable to such request (with the substitution of Section 1.4 for references to Section 1.2). 

(d) Subject to the foregoing, the Company shall file a Form S-3 registration statement covering the Registrable Securities and other
securities so requested to be registered as soon as practicable after receipt of the request or requests of the Holders. Registrations effected pursuant to this Section 1.4 shall not be counted as requests for registration effected pursuant to
Section 1.2. Except as otherwise provided herein, there shall be no limit on the number of times the Holders may request registration of Registrable Securities under this Section 1.4. 

1.5 Obligations of the Company 
 Whenever required under this Section 1 to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 

(a) prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its commercially
reasonable best efforts to cause such registration 

  
 -7-

 
statement to become effective, and, upon the request of the Holders of two-thirds (2/3) of the Registrable Securities registered thereunder, keep such registration statement effective for a
period of up to one hundred twenty (120) days or, if earlier, until the distribution contemplated in the registration statement has been completed; 
 (b) prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary or advisable to
comply with the provisions of the Act with respect to the disposition of all securities covered by such registration statement for the period set forth in paragraph (a) above; 

(c) furnish to the Holders such numbers of copies of a prospectus, including a preliminary prospectus, in conformity with the
requirements of the Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; 
 (d) use its commercially reasonable best efforts to register and qualify the securities covered by such registration statement under such other securities or “blue sky” laws of such
jurisdictions as shall be reasonably requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such
states or jurisdictions not already so qualified or consented; 
 (e) in the event of any underwritten public offering, enter
into and perform its obligations under an underwriting agreement, in usual and customary form, with the managing underwriter of such offering; 
 (f) notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is required to be delivered under the Act or the happening of any
event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements
therein not misleading in the light of the circumstances then existing; 
 (g) cause all such Registrable Securities registered
pursuant to this Agreement to be listed on each securities exchange and/or quoted on each broker-dealer network on which similar securities issued by the Company are then listed and/or quoted; 

(h) provide a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and a CUSIP number for
all such Registrable Securities, in each case not later than the effective date of such registration; and 
 (i) use its best
efforts to furnish, at the request of any Holder requesting registration of Registrable Securities pursuant to this Section 1, on the date that such Registrable Securities are delivered to the underwriters for sale in connection with a
registration pursuant to 

  
 -8-

 
this Section 1, if such securities are being sold through underwriters, or, if such securities are not being sold through underwriters, on the date that the registration statement with
respect to such securities becomes effective, (x) an opinion, dated such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten
public offering, addressed to the underwriters, if any, and to the Holders requesting registration of Registrable Securities, and (y) a letter dated such date, from the independent certified public accountants of the Company, in form and
substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the underwriters, if any, and to the Holders requesting registration of Registrable Securities.

 1.6 Information from Holder 
 It shall be a condition precedent to the obligations of the Company to take any action pursuant to this Section 1 with respect to the Registrable Securities of any selling Holder that such Holder
shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of such securities as shall be required to effect the registration of such Holder’s Registrable
Securities. 
 1.7 Expenses of Registration 

All expenses other than underwriting discounts, commissions and stock transfer taxes incurred in connection with registrations, filings
or qualifications pursuant to Sections 1.2, 1.3 and 1.4, including (without limitation) all registration, filing and qualification fees, printer’s and accounting fees, fees and disbursements of counsel for the Company and the reasonable fees of
one special counsel for the selling Holders (not to exceed $25,000) shall be borne by the Company. Notwithstanding the foregoing, the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to
Section 1.2 or Section 1.4 if the registration request is subsequently withdrawn at the request of the Holders of two-thirds (2/3) of the Registrable Securities to be registered (in which case all participating Holders shall bear such
expenses pro rata based upon the number of Registrable Securities that were to be requested in the withdrawn registration), unless (i) in the case of a registration requested under Section 1.2, the Holders of two-thirds (2/3) of the
Registrable Securities agree to forfeit their right to one (1) demand registration pursuant to Section 1.2; (ii) at the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business or
prospects of the Company from that known to the Holders at the time of their request and have withdrawn the request with reasonable promptness following disclosure by the Company of such material adverse change, then the Holders shall not be
required to pay any of such expenses and shall retain their rights pursuant to Section 1.2; and (iii) in the case of a registration request under Section 1.4, the holders of two-thirds (2/3) of the Registrable Securities agree
that the withdrawn registration shall be counted as one (1) request for registration under Section 1.4(b)(4). 
 1.8
Delay of Registration 
 No Holder shall have any right to obtain or seek an injunction restraining or otherwise

  
 -9-

 
delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 1. 

1.9 Indemnification 
 In the event any Registrable Securities are included in a registration statement under this Section 1: 
 (a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder, the partners or officers, directors, members and stockholders of each Holder, legal counsel and accountants
for each Holder, any underwriter (as defined in the Act) for such Holder and each person, if any, who controls such Holder or underwriter within the meaning of the Act or the 1934 Act, against any losses, claims, damages or liabilities (joint or
several) to which they may become subject under the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated thereunder, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of
or are based upon any of the following statements, omissions or violations (collectively a “Violation”): (i) any untrue statement or alleged untrue statement of a material fact contained in such registration statement,
including any preliminary or final prospectus contained therein, and any amendments, supplements or exhibits thereto, or in any state “blue sky” filing required in connection therewith, (ii) the omission or alleged omission to state
therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by the Company of the Act, the 1934 Act, any state securities laws or any rule or
regulation promulgated under the Act, the 1934 Act or any state securities laws, and the Company will reimburse each such Holder, underwriter, controlling person or other aforementioned person for any legal or other expenses reasonably incurred by
them in connection with investigating or defending any such loss, claim, damage, liability or action as such expenses are incurred, provided, however, that the indemnity agreement contained in this Section l.9(a) shall not apply to
amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in any such case
for any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon a Violation that occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such
registration by any such Holder, underwriter, controlling person or other aforementioned person, and provided further, that the foregoing indemnity agreement with respect to any preliminary prospectus shall not inure to the benefit of
any Holder or underwriter or other aforementioned person, or any person controlling such Holder or underwriter, from whom the person asserting any such losses, claims, damages or liabilities purchased shares in the offering, if a copy of the
prospectus (as then amended or supplemented if the Company shall have furnished any amendments or supplements thereto) was not sent or given by or on behalf of such Holder or underwriter or other aforementioned person to such person, if required by
law so to have been delivered, at or prior to the written confirmation of the sale of the shares to such person, and if the prospectus (as so amended or supplemented) would have cured the defect giving rise to such loss, claim, damage or liability.

  
 -10-

 (b) To the extent permitted by law, each selling Holder will severally but not jointly
indemnify and hold harmless the Company, each of its directors, each of its officers who has signed the registration statement, each person, if any, who controls the Company within the meaning of the Act, legal counsel and accountants for the
Company, any underwriter, any other Holder selling securities in such registration statement and any controlling person of any such underwriter or other Holder, against any losses, claims, damages or liabilities to which any of the foregoing persons
may become subject, under the Act, the 1934 Act, any state securities laws or any rule or regulation promulgated thereunder, insofar as such losses, claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any
Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder expressly for use in connection with such registration, and each such
Holder will reimburse any person intended to be indemnified pursuant to this Section l.9(b), for any legal or other expenses reasonably incurred by such person in connection with investigating or defending any such loss, claim, damage, liability or
action as such expenses are incurred, provided, however, that the indemnity agreement contained in this Section 1.9(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such
settlement is effected without the consent of the Holder (which consent shall not be unreasonably withheld), provided that in no event shall any indemnity under this Section l.9 exceed the net proceeds from the offering received by such
Holder. 
 (c) Promptly after receipt by an indemnified party under this Section 1.9 of notice of the commencement of any
action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 1.9, deliver to the indemnifying party a written notice of the commencement
thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually
satisfactory to the parties, provided, however, that an indemnified party (together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with
the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified
party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if prejudicial to its ability to defend such
action, shall relieve such indemnifying party of any liability to the indemnified party under this Section 1.9 only to the extent of such prejudice, but the omission so to deliver written notice to the indemnifying party will not relieve it of
any liability that it may have to any indemnified party otherwise than under this Section 1.9. 
 (d) If the
indemnification provided for in this Section 1.9 is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to herein, then the indemnifying
party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable 

  
 -11-

 
by such indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one
hand and of the indemnified party on the other in connection with the statements or omissions that resulted in such loss, liability, claim, damage or expense, as well as any other relevant equitable considerations, provided, however,
that no contribution from any Holder, when combined with any amounts paid by such Holder pursuant to Section 1.9, shall exceed the proceeds from the offering received by such Holder. The relative fault of the indemnifying party and of the
indemnified party shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the indemnifying party or by the
indemnified party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission. 
 (e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public
offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 
 (f) The
obligations of the Company and Holders under this Section 1.9 shall survive the completion of any offering of Registrable Securities in a registration statement under this Section 1, and otherwise. 

1.10 Reports Under the 1934 Act 
 With a view to making available to the Holders the benefits of Rule 144 promulgated under the Act and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the
Company to the public without registration or pursuant to a registration on Form S-3, the Company agrees to: 
 (a) make and
keep public information available, as those terms are understood and defined in SEC Rule 144 (or any successor rule promulgated under the Act “Rule 144”), at all times after the effective date of the initial public offering
of the Company’s equity securities, 
 (b) file with the SEC in a timely manner all reports and other documents required of
the Company under the Act and the 1934 Act; and 
 (c) furnish to any Holder, so long as the Holder owns any Registrable
Securities, forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of Rule 144 (at any time after ninety (90) days after the effective date of the first registration statement
filed by the Company), the Act and the 1934 Act (at any time after it has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after it so qualifies),
(ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company with the SEC, and (iii) such other information as may be reasonably requested in availing any Holder of
any rule or regulation of the SEC that permits the 

  
 -12-

 
selling of any such securities without registration or pursuant to such form. 
 1.11 Assignment of Registration Rights 
 The rights to cause the
Company to register Registrable Securities pursuant to this Section 1 may be assigned (but only with all related obligations) by a Holder to a transferee or assignee of such securities that (i) is a partner, limited partner or retired
partner of a Holder that is a partnership, (ii) is a member or retired member of any Holder that is a limited liability company, (iii) is a spouse, domestic partner, sibling, lineal descendant or ancestor of a Holder (whether adoptive or
natural), or any trust established for the benefit of a Holder or any spouse, domestic partner, sibling, lineal descendant or ancestor of a Holder (whether adoptive or natural), (iv) is an affiliate of the Holder, as that term is defined in
Rule 405 of the Securities Act or (v) after such assignment or transfer, holds at least 100,000 shares of Registrable Securities (subject to appropriate adjustment for stock splits, stock dividends, combinations and other recapitalizations) (or
such lesser amount if the Holder is transferring all Registrable Securities held by the Holder), provided: (a) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such
transferee or assignee and the securities with respect to which such registration rights are being assigned, (b) such transferee or assignee agrees in writing to be bound by and subject to the terms and conditions of this Agreement, including
without limitation the provisions of Section 1.13 below, and (c) such assignment shall be effective only if immediately following such transfer the further disposition of such securities by the transferee or assignee is restricted under
the Act. 
 1.12 Limitations on Subsequent Registration Rights 

From and after the date of this Agreement, the Company shall not, without the prior written consent of the Investors holding two-thirds
(2/3) of the Registrable Securities held by the Investors, enter into any agreement with any holder or prospective holder of any securities of the Company that would allow such holder or prospective holder: (a) to include such securities
in any registration filed under Section 1.2, Section 1.3 or Section 1.4 hereof, unless under the terms of such agreement, such holder or prospective holder may include such securities in any such registration only to the extent that
the inclusion of such securities will not reduce the amount of the Registrable Securities of the Holders that are included, or (b) to demand registration of their securities, or (c) to exercise other registration rights that are pari passu
or senior to those granted to the Holders hereunder. 
 1.13 Market Stand-off Agreement 

Each Holder hereby agrees that it will not, without the prior written consent of the managing underwriter, during the period commencing
on the date of the final prospectus relating to the Company’s initial public offering and ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred and eighty (180) days) following the
effective date of the registration statement for such offering, if so required by the underwriters of such offering, (i) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to
sell, grant any option, right or warrant to 

  
 -13-

 
purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock (whether such
shares or any such securities are then owned by the Holder or are thereafter acquired), or (ii) enter into any swap, hedging or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of
the Common Stock, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or such other securities, in cash or otherwise. The foregoing provisions of this Section 1.13 shall not
apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, and shall only be applicable to the Holders if all officers, directors and one percent (1%) stockholders of the Company enter into similar agreements. The
underwriters in connection with the Company’s initial public offering are intended third party beneficiaries of this Section 1.13 and shall have the right, power and authority to enforce the provisions hereof as though they were a party
hereto. In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to the Registrable Securities of each Holder (and the shares or securities of every other person subject to the foregoing restriction)
until the end of such period. 
 1.14 Termination of Registration Rights 

No Holder shall be entitled to exercise any right provided for in this Section 1 after the earliest of, (a) five (5) years
following an initial public offering in which all Preferred Stock of the Company is automatically converted into shares of Common Stock under the Company’s Fourth Amended and Restated Certificate of Incorporation, as may be amended (the
“Restated Certificate”), or (b) as to any Holder, such time at which all Registrable Securities held by such Holder (and any affiliate of the Holder with whom such Holder must aggregate its sales under Rule 144) can be
sold in any three (3) month period without registration in compliance with Rule 144 of the Act. 
 2. Covenants 

The Company hereby covenants to each of the Investors as follows: 

2.1 Delivery of Financial Statements 
 The Company shall deliver to each Investor or transferee who holds at least 500,000 shares of Common Stock on an as converted, as exercised basis, as adjusted for splits, dividends, combinations and other
recapitalizations (a “Major Investor”): 
 (a) as soon as practicable, but in any event within ninety
(90) days after the end of each fiscal year of the Company, an income statement for such fiscal year, a balance sheet of the Company and statement of stockholder’s equity as of the end of such year, and a statement of cash flows for such
year, such year-end financial reports to be in reasonable detail, prepared in accordance with generally accepted accounting principles (“GAAP”) and commencing with the financial reports for the fiscal year end 2008, audited
by the Company’s accounting firm; 
 (b) as soon as practicable, but in any event within forty-five (45) days after
the 

  
 -14-

 
end of each of the first three (3) quarters of each fiscal year of the Company, an unaudited income statement, an unaudited statement of cash flows for such fiscal quarter and an unaudited
balance sheet as of the end of such fiscal quarter, each of the foregoing income statement, statement of cash flows and balance sheet also to set forth in comparative form the budgeted amounts for such period and the corresponding figures for the
period in the prior fiscal year, to be in reasonable detail and prepared in accordance with GAAP; 
 (c) within thirty days
(30) of the end of each month, an unaudited income statement and statement of cash flows and an unaudited balance sheet for and as of the end of such month, in reasonable detail, each of the foregoing income statement, statement of cash flows
and balance sheet also to set forth in comparative form the budgeted amounts for such period and the corresponding figures for the period in the prior fiscal year, to be in reasonable detail, prepared in accordance with GAAP; 

(d) as soon as practicable, but in any event at least thirty (30) days prior to the end of each (A) fiscal year and
(B) second fiscal quarter, a budget and business plan for the remainder of the fiscal year (which shall set forth the use of proceeds raised in the transactions under the Purchase Agreement), next fiscal year or semi-annual period, prepared on
a monthly basis (including balance sheets, income statements and statements of cash flows for such months), which plan shall be acceptable to the Company’s Board of Directors, including a majority of the directors elected by the holders of
Series A Preferred Stock and Series B Preferred stock (the “Preferred Directors”); provided that any material changes or deviations to the budget or the Company’s actions in executing the budget shall require the
approval of the Board of Directors, including a majority of the Preferred Directors; and 
 (e) with respect to the financial
statements called for in subsections (a), (b) and (c) of this Section 2.1, an instrument executed by the Chief Financial Officer or President of the Company certifying that such financial statements (i) were prepared accordance
with GAAP consistently applied with prior practice for earlier periods (with the exception of footnotes that may be required by GAAP) and (ii) fairly present the financial condition of the Company and its results of operation for the period
specified, subject to year-end audit adjustment; provided that if no accounting professional knowledgeable of GAAP is employed by the Company then such certification shall be provided by the President of the Company certifying only as to (ii).

 2.2 Inspection 
 The Company shall permit each Major Investor, at such Major Investor’s expense, to visit and inspect the Company’s properties, to examine its books of account and records and to discuss the
Company’s affairs, finances and accounts with its executive officers, all at such reasonable times as may be requested by the Major Investor, provided, however, that the Company shall not be obligated pursuant to this
Section 2.2 to provide access to any information that it reasonably considers to be a trade secret or similar confidential information if, in consultation with legal counsel, the Company determines that providing such access would compromise
the Company’s rights with respect to such information, unless such Major Investor delivers a confidentiality and 

  
 -15-

 
non-disclosure agreement in form and substance satisfactory to the Company’s legal counsel. 
 2.3 Right of First Offer 
 (a) Subject to the terms and conditions
specified in this Section 2.3, if the Company proposes to issue Additional Shares of Common Stock (as defined below), it shall provide each Major Investor, with a written notice (the “Issuance Notice”) stating
(i) its bona fide intention to offer such Additional Shares of Common Stock, (ii) the number of such Additional Shares of Common Stock to be offered, and (iii) the price and terms upon which it proposes to offer such Additional Shares
of Common Stock. By written notification received by the Company, within fifteen (15) calendar days after receipt of the Issuance Notice, each Major Investor may elect to purchase or obtain, at the price and on the terms specified in the
Issuance Notice, up to that portion of such Additional Shares of Common Stock (such holder’s “Pro-Rata Portion”) that equals the proportion that the number of shares of Common Stock on an as converted as exercised basis
then held by such Holder bears to the total number of shares of Common Stock of the Company then outstanding, including the Common Stock issuable upon conversion of all outstanding Preferred Stock, upon conversion of all other outstanding
convertible securities, and upon exercise of all outstanding options (and assuming conversion of convertible securities issuable upon exercise of options), excluding authorized but unissued options. 

(b) In the event that such Major Investor fails to give such notice within the prescribed period, or otherwise fails to purchase its
Pro-Rata Portion of such Additional Shares of Common Stock the Company shall promptly inform in writing each Major Investor that has elected to purchase its full Pro-Rata Portion (a “Fully-Exercising Investor”) of any other
Major Investor’s failure to do so. During the ten (10) day period commencing after the delivery of such supplemental notice, each Fully-Exercising Investor shall be entitled to obtain its Pro-Rata Portion of the Additional Shares of Common
Stock not purchased by other Major Investors. For the purposes of this Section 2.3, Major Investor includes any managers, general partners and affiliates of a Major Investor. A Major Investor shall be entitled to apportion the right of first
offer hereby granted it among itself and its partners and affiliates in such proportions as it deems appropriate. 
 (c) If all
Additional Shares of Common Stock that Major Investors are entitled to purchase pursuant to Section 2.3(a) and (b) are not elected to be purchased as provided in Section 2.3(a) and (b) hereof, the Company may, during the forty
five (45) day period following the expiration of the period provided in Section 2.3(a) or (b) hereof, as the case may be, offer the remaining unsubscribed portion of such Additional Shares of Common Stock to any person or persons at a
price not less than, and upon terms no more favorable to the offeree than those specified in the Issuance Notice. If the Company does not enter into an agreement for the sale of the Additional Shares of Common Stock within such period, or if such
agreement is not consummated within forty five (45) days of the execution thereof, the right provided hereunder shall be deemed to be revived and such Additional Shares of Common Stock shall not be offered unless first reoffered to the Major
Investors in accordance herewith. 

  
 -16-

 (d) For purposes of this Section 2.3, the following definitions shall apply:

 (i) “Additional Shares of Common Stock” shall mean all shares of Common Stock issued (or deemed to
be issued pursuant to Section 2.3(e) below) by the Company after the date of this Agreement, other than as follows: 
 (A)
upon conversion of shares of the Company’s Preferred Stock; 
 (B) shares of the Company’s Common Stock, or Options
to purchase Common Stock issued to officers, directors, employees of, consultants and service providers to the Company pursuant to plans or arrangements approved by the Board of Directors; 

(C) as a dividend or other distribution on the Preferred Stock, or any other event for which adjustment is made pursuant to the Restated
Certificate; 
 (D) upon the exercise or conversion of Options or Convertible Securities that were outstanding prior to the
date of this Agreement; 
 (E) capital stock, or Options to purchase capital stock, issued to financial institutions, lenders
or lessors in connection with bona fide commercial credit arrangements, equipment financings, commercial property leases, or similar transactions, the terms of which have been approved by a majority of the Board of Directors including a majority of
the Preferred Directors; 
 (F) capital stock or Options to purchase capital stock issued in connection with bona fide
acquisitions, mergers, strategic partnership transactions or similar transactions, the terms of which have been approved by a majority of the Board of Directors including a majority of the Preferred Directors; 

(G) shares of capital stock issued or issuable in a public offering; 

(H) Common Stock issued or deemed issued as a result of a decrease in the conversion price of any series of Preferred Stock resulting
from the operation of the Restated Certificate; 
 (I) by way of dividend or other distributions on securities referred to in
subsections (A) through (H) above. 
 (ii) “Convertible Securities” shall mean instruments of
indebtedness or securities convertible into or exchangeable for Common Stock including without limitation, shares of the Company’s Preferred Stock. 
 (iii) “Options” shall mean rights, options or warrants to subscribe for, 

  
 -17-

 
purchase or otherwise acquire shares of the Company’s Common Stock or Convertible Securities. 
 (e) If the Company at any time after the date of this Agreement shall issue any Options or Convertible Securities, then the maximum number of shares (as set forth in the instrument relating thereto
without regard to any provisions contained therein for a subsequent adjustment of such number) of Common Stock issuable upon the exercise of such Options or, in the case of Convertible Securities and Options for Convertible Securities, the
conversion or exchange of such Convertible Securities, shall be deemed to be Additional Shares of Common Stock issued as of the time of such issuance. 
 (f) The right of first offer in this Section 2.3 shall not be applicable with respect to any Major Investor with regard to any issue of Additional Shares of Common Stock, if (x) at the time of
such issue of Additional Shares of Common Stock, such Major Investor is not an accredited investor, and (y) such issue of Additional Shares of Common Stock is otherwise being offered only to accredited investors. 

(g) The rights provided in this Section 2.3 may not be assigned or transferred by any Major Investor; provided,
however, that a Major Investor may assign or transfer such rights to an affiliate, general partner or manager of such Major Investor. 
 2.4 IPO Participation Right 
 In connection with the first public
offering of the Company’s securities, the Company hereby covenants it shall uses its reasonable good faith efforts to have the managing underwriter offer Fayez Sarofim Investment Partnership No. 5, L.P. and/or its affiliates
(“Sarofim”), Accel IX L.P. and/or its affiliates (“Accel”), Sequoia Capital XII, L.P. and/or its affiliates (“Sequoia”), Deep Fork Capital L.L.C. and/or its affiliates
(“Deep Fork”) or their designees, within ten (10) business days of the filing of the registration statement with respect to such offering (which registration statement shall cover the securities to be offered to Sarofim,
Accel, Sequoia and Deep Fork pursuant to this Section 2.4) up to ten percent (10%), in the aggregate, of the shares sold in such offering, to be allocated between them on a pro-rata basis in proportion to their respective ownership of
Registrable Securities, provided that each of them shall have the right to any portion of the 10% not elected by the other, or as otherwise may be agreed upon by them. Notwithstanding any other provision in this Section 2.4, if the managing
underwriter reasonably determines that marketing factors or applicable regulatory restrictions require a limitation of the number of shares being underwritten, the managing underwriter, may limit Sarofim’s, Accel’s, Sequoia’s and Deep
Fork’s foregoing right, including a limitation which would exclude all such shares from such initial public offering, but only to the extent reasonably necessary. 
 2.5 Expenses 
 The Company shall pay the reasonable out-of-pocket
expenses incurred by non-employee directors in connection with their attendance at Board of Directors meetings, meetings of the committees thereof or other Company-authorized business. 

  
 -18-

 2.6 Director and Officer Insurance 

The Company shall use its reasonable best efforts to maintain its director and officer liability insurance in a reasonable amount
specified by a majority of the Board of Directors, including a majority of the Preferred Directors, but shall be no more than $3,000,000 and on such terms as are approved by a majority of the directors of the Company, including a majority of the
Preferred Directors. 
 2.7 Board Committees; Executive Compensation and Related Party Transactions 

Upon approval of a majority of the directors, including a majority of the Preferred Directors, the Company agrees to establish an Audit
Committee, a Compensation Committee and Executive Committee, (the “Committees”) as soon as practicable in no event later than ninety (90) days after the date of such approval. Each Committee shall have at
least two members, a majority of whom shall be independent. The Preferred Directors (as defined in the Restated Certificate) shall have the right to sit on each Committee, to the extent such Committee exits. All (a) compensation of executives
of the Company (whether consisting of cash, equity or otherwise), (b) all capital stock, Options and Convertible Securities issuances that are compensatory in nature and (c) transactions of the Company with any founder, current or former
officer, director or greater than 5% stockholder or any such person’s affiliates or family members, of the Company, including any amendment to any agreement with any such person in existence as of the date hereof, shall require the approval of
the Compensation Committee (which shall mean the affirmative approval of a majority of its members including at least two members), and if there is no such Committee, then by the disinterested/independent directors of the Board of Directors and the
Preferred Directors. For the purposes of this Section 2.7, independent director shall mean any director not a Common Director (as defined in the Restated Certificate). 
 2.8 Drag-Along Rights 
 (a) Anything contained herein to the
contrary notwithstanding, if at any time (1) the Board of Directors, (2) the holders of two-thirds (2/3) of the outstanding shares of Preferred Stock and (3) the holders of seventy-five percent (75%) of the outstanding
shares of Common Stock, each voting as a separate class, shall approve a bona fide proposal from a third party with respect to a sale of the Company whether by merger, asset or stock sale or otherwise, for a specified price payable in cash or
otherwise and on specified terms and conditions (a “Sale Proposal”), then the Company shall deliver a notice (a “Required Sale Notice”) with
respect to such Sale Proposal to all Investors and to the Common Holders (together, the “Stockholders”) stating that the Company proposes to effect the Sale Proposal and providing the identity of the persons involved in such
Sale Proposal and the terms thereof. Each such Stockholder and each Stockholder’s transferee, upon receipt of a Required Sale Notice, shall be obligated, which obligation shall be enforceable by the Company, to sell its stock and participate in
the transaction (a “Required Sale”) contemplated by the Sale Proposal, vote its shares of stock in favor of such Sale Proposal at any meeting of stockholders called to vote on or approve such Sale
Proposal and 

  
 -19-

 
otherwise to take all necessary action to cause the Company and the Stockholders to consummate such Required Sale. Any such Required Sale Notice may be rescinded by the Company by delivering
written notice thereof to all the Stockholders. 
 (b) The obligations of the Stockholders pursuant to this Section 2.8 are
subject to the satisfaction of the following conditions: 
 (1) no Stockholder shall be obligated to make any out-of-pocket
expenditure prior to the consummation of the Required Sale and no Stockholder shall be obliged to pay more than such Stockholder’s pro rata share (based upon the amount of consideration received) of reasonable expenses incurred in connection
with a consummated Required Sale to the extent such costs are incurred for the benefit of all Stockholders and are not otherwise paid by the Company or the acquiring party (costs incurred by or on behalf of a Stockholder for such Stockholder’s
sole benefit will not be considered costs of the transaction hereunder), provided that a Stockholder’s liability for such expenses shall be capped at the total purchase price received by such Stockholder for such Stockholder’s shares of
stock (including the exercise price thereof); 
 (2) in the event that the Stockholders are required to provide any
representations or indemnities in connection with the Required Sale (other than representations and indemnities concerning each Stockholder’s valid ownership of such Stockholder’s shares of stock, free of all liens and encumbrances (other
than those arising under applicable securities laws), and each Stockholder’s authority, power, and right to enter into and consummate such purchase or merger agreement without violating any other agreement), then each Stockholder shall not be
liable for more than such Stockholder’s pro rata share (based upon the amount of consideration received) of any liability for misrepresentation or indemnity and such liability shall not exceed the total purchase price received by such
Stockholder for such Stockholder’s shares of stock (including the exercise price thereof); and 
 (3) the total purchase
price received by the preferred stockholder shall equal or exceed their respective liquidation preference plus all declared but unpaid dividends on such shares as set forth in Section 2(a) of Article IV of the Restated Articles. 

2.9 Reserved 
 2.10 Termination of Covenants 
 The covenants set forth in
Section 2 shall terminate and be of no further force or effect (i) upon the consummation of a public offering of securities by the Company in which all Preferred Stock then outstanding automatically converts into Common Stock under the
terms of the Restated Certificate, or (ii) for purposes of Sections 2.1 and 2.2 only, at such time as the Company becomes subject to the reporting provisions of the 1934 Act. 

  
 -20-

 3. Miscellaneous 
 3.1 Legend 
 Each certificate evidencing any of the Registrable
Securities shall bear a legend substantially as follows: 
 “THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO
THE TERMS AND CONDITIONS OF A CERTAIN INVESTOR RIGHTS AGREEMENT BY AND AMONG THE COMPANY, THE HOLDER HEREOF AND CERTAIN OTHER HOLDERS OF THE COMPANY’S SECURITIES, AND MAY NOT BE SOLD, TRANSFERRED OR ENCUMBERED EXCEPT IN ACCORDANCE WITH THE
TERMS AND PROVISIONS OF SAID AGREEMENT, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL EXECUTIVE OFFICE OF THE COMPANY AND WILL BE FURNISHED TO THE HOLDER OF THIS CERTIFICATE UPON REQUEST AND WITHOUT CHARGE.” 

3.2 Successors and Assigns 
 Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective successors and assigns of the parties hereto (including
transferees of any shares of Registrable Securities). Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or
liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 
 3.3 Governing
Law 
 This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto
shall be governed by and construed under the laws of the State of California, as applied to agreements among California residents entered into and to be performed entirely within California without giving effect to principles of conflicts of law
thereof. 
 3.4 Counterparts 
 This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of which together shall constitute one and the same instrument. 

3.5 Titles and Subtitles 
 The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement. 

  
 -21-

 3.6 Notices 

Unless otherwise provided, any notice under this Agreement shall be given in writing and shall be deemed effectively delivered
(a) upon personal delivery to the party to be notified, (b) upon confirmation of receipt by facsimile by the party to be notified, (c) one (1) business day after deposit with a reputable overnight courier, prepaid for overnight
delivery and addressed as set forth in (d), or (d) three (3) days after deposit with the United States Postal Service, postage prepaid, registered or certified with return receipt requested and addressed to the party to be notified at the
address indicated for such party on the exhibits hereto, or at such other address as such party may designate by written notice to the other party given in the foregoing manner. 

3.7 Entire Agreement; Amendments and Waivers 
 This Agreement (including the exhibits hereto) and the documents referred to herein constitute the full and entire understanding and agreement among the parties hereto with regard to the subjects hereof
and thereof, and no party shall be liable or bound to any other party in any manner by any warranties, representations, or covenants, except as specifically set forth herein or therein. Without limiting the foregoing, this Agreement amends and
restates the Existing Investor Rights Agreement in its entirety and all of the terms of the Existing Investor Rights Agreement are superseded by the terms of this Agreement and are of no further force and effect. Any term of this Agreement (other
than Sections 2.1, 2.2 and 2.3) may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and
the holders of two-thirds (2/3) of the Registrable Securities, provided, however, that in the event that such amendment or waiver adversely affects the obligations or rights of the Common Holders in a different manner than the
other Holders, such amendment or waiver shall also require the written consent of the holders of a majority of Common Stock held by the Common Holders. Notwithstanding the foregoing, the amendment of this Agreement to include additional parties as
Investors or Common Holders, or additional shares as Registrable Securities, whether pursuant to the Purchase Agreement or any future transaction or agreement, shall not require the separate consent of the Common Holders. Sections 2.1, 2.2 and 2.3
may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and Major Investors holding two-thirds (2/3) of the
Registrable Securities held by all such Major Investors. Notwithstanding anything to the contrary provided for herein, (i) no amendment and/or waiver that would adversely affect a Series D Investor in a manner differently than other Investors
(other than an effect based on such Investor’s pro rata holdings) may be made without the written consent of the Company and such Series D Investor and (ii) no amendment and/or waiver that would adversely affect the Investors holding
Series D Preferred Stock in a manner differently than the Investors holding any other series of Preferred Stock (other than an effect based on such Investors’ respective pro rata holdings) may be made without the written consent of the Company
and the Investors holding at least a majority of the shares of Series D Preferred then held by the Investors. Any amendment or waiver effected in accordance with this paragraph shall be binding upon each Holder of any Registrable Securities, each
future Holder of any Registrable Securities 

  
 -22-

 
and the Company. 
 3.8 Waiver 

Each of the Series A Investors, Series B Investors, and Series C Investors hereby waives any right of notice or pro-rata rights with
respect to the sale of the Series D Preferred Stock pursuant to the terms of the Purchase Agreement, to which the Investor may be entitled pursuant to the Existing Investor Rights Agreement, except to the extent participating under the Purchase
Agreement. Such waiver shall be binding upon all parties to the Existing Investor Rights Agreement. 
 3.9
Severability 
 If one or more provisions of this Agreement are held to be unenforceable under applicable law,
such provision shall be excluded from this Agreement and the balance of this Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms. 

3.10 Aggregation of Stock 
 All shares of Registrable Securities held or acquired by affiliated entities or persons shall be aggregated together for the purpose of determining the availability of any rights under this Agreement.

 3.11 Expenses 
 If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary
disbursements in addition to any other relief to which such party may be entitled. 
 [SIGNATURE PAGES FOLLOW] 

  
 -23-

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

	
	COMPANY:
	
	TRULIA, INC.
	
	 /s/ Peter Flint

	Peter Flint, CEO

  
 SIGNATURE
PAGE TO TRULIA, INC. 
 THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

			
	INVESTORS:
	
	 DEEP FORK CAPITAL L.L.C.,
 a Delaware limited liability company

		
	By:	 	 /s/ Aubrey K. McClendon

		 	Aubrey K. McClendon,
		 	Manager

 
			
		
	Address:	 	 3000 Sand Hill Road, Bldg. 2, Suite 120
 Menlo Park, CA 94025

 
			
		
	Telephone:	 	  

 

			
	Facsimile No.:	 	  

 

			
	E-mail Address:	 	  

  
 SIGNATURE
PAGE TO TRULIA, INC. 
 THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

			
	INVESTORS:
	
	QCP FUND A
		
	By:	 	 /s/ Frank P. Quatronne

		
		 	 Frank P. Quatronne

Title: Chairman, Qatalyst Partners LLC,

the General Partner of QCP Fund A

 
			
		
	Address:	 	 3 Embarcadero Center, Sixth Floor
 San Francisco, CA 94111

	 Telephone: 

Facsimile No: 
 Email Address:

  
 SIGNATURE
PAGE TO TRULIA, INC. 
 THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

					
	INVESTORS:
	
	 SEQUOIA CAPITAL XII
 SEQUOIA TECHNOLOGY PARTNERS XII
 SEQUOIA CAPITAL XII PRINCIPALS
FUND

		
	By:	 	SC XII Management, LLC
		 	A Delaware Limited Liability Company
		 	General Partner of Each
		
	By:	 	 /s/ Brian Schreier

		 	Managing Member

 
					
			
	Address:	 		 	 3000 Sand Hill Road
 Building
4, Suite 180
 Menlo Park, CA 94025

Attn: Sameer Gandhi

	
	 Telephone: 

Facsimile No.: 
 E-mail Address:

  
 SIGNATURE
PAGE TO TRULIA, INC. 
 THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

			
	INVESTORS:
	
	ACCEL IX L.P.
		
	By:	 	Accel IX Associates L.L.C.
	Its:	 	General Partner
		
	By.	 	 /s/ Rich Zamboldi

		 	Attorney in Fact
	
	ACCEL IX STRATEGIC PARTNERS L.P.
		
	By:	 	Accel IX Associated L.L.C.
	Its:	 	General Partner
		
	By:	 	 /s/ Rich Zamboldi

		 	Attorney in Fact
	
	ACCEL INVESTORS 2005 L.L.C.
		
	By:	 	 /s/ Rich Zamboldi

		 	Attorney in Fact

 
					
		
	Address:	 	 428 University Avenue
 Palo Alto, CA 94301

		 	Attn:	 	 Theresia Gouw Ranzetta
 Rich
Zamboldi

 
			
	
	 Telephone: 

Facsimile No.:

	E-mail Address:	 	

  
 SIGNATURE
PAGE TO TRULIA, INC. 
 THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above
written. 
  

					
	INVESTORS:
	
	FAYEZ SAROFIM INVESTMENT PARTNERSHIP NO. 5, L.P.
	
	By: FSJ No. 2 Corporation
	Its: Managing General Partner
		
	By:	 	 /s/ Raye G. White

		 	Raye G. White
		 	Executive Vice President

 
					
		
	Address:	 	 Two Houston Center

Suite 2907
 Houston, TX 77010

Attn: David Pesikoff

	
	 Telephone: 

Facsimile No.: 

  
 SIGNATURE
PAGE TO TRULIA, INC. 
 THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement us of the date first above
written. 
  

	
	COMMON HOLDERS:
	
	PETER FLINT
	
	 /s/ Peter Flint

	
	SAMI MARKUS INKINEN
	
	  

  
 SIGNATURE
PAGE TO TRULIA, INC. 
 THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date fiat above
written. 
  

	
	COMMON HOLDERS:
	
	PETER FLINT
	  

	
	SAMI MARKUS INKINEN
	
	 /s/ Sami Markus Inkinen

  
 SIGNATURE
PAGE TO TRULIA, INC. 
 THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT 

 EXHIBIT A 

SCHEDULE OF SERIES A INVESTORS 
  

			
	Name and Address	  	
		
	Fayez Sarofim Investment Partnership #5, LP	  	Ronald & Gayle Conway
		  	as Trustees of the Conway Family
	 1811 Family Partnership, Ltd.
	  	Trust dated 9/25/96
		  	
	Kathryn L. E. Rabinow Trust	  	Claudio Chiuchiarelli
		
	 Waldorf Volpi Partnership 
	  	The Gary and Loretta Durbin Trust
		
	 Gregory L. Waldorf
	  	 David & Sarah Hehman

		
	 Holdstein Revocable Trust
	  	 Thorner Ventures

		
	 Howard & Harriet Love Living Trust of 11/94
	  	 TWB Investment Partnership II, L.P.

		
	 Kevin E. Hartz
	  	 Andrew K. Boszhardt, Jr.

		
		  	
		
		  	
		
		  	

 EXHIBIT B 

SCHEDULE OF SERIES B INVESTORS 
  

					
	Name and Address	  	 
		
	Accel IX L.P.	  	Fayez Sarofim Investment Partnership #5, LP
		
	Accel IX Strategic Partners L.P.	  	1811 Family Partnership, Ltd.
		
	Accel Investors 2005 L.L.C.	  	Kathryn L. E. Rabinow Trust
		
	Holdstein Revocable Trust	  	Waldorf Volpi Partnership
		
	Thorner Ventures	  	Gregory L. Waldorf
		
	James Gutierrez	  	The Board of Trustees of the Leland Stanford
		  	Junior University (DAPER I)

 EXHIBIT C 

SCHEDULE OF SERIES C INVESTORS 
  

			
	Name and Address	  	 
		
	Sequoia Capital XII, L.P.	  	Accel IX L.P.
		
	Accel IX Strategic Partners L.P.	  	Accel Investors 2005 L.L.C.
		
	Fayez Sarofim Investment Partnership #5, LP	  	

 EXHIBIT D 

SCHEDULE OF SERIES D INVESTORS 
  

			
	Name and Address	  	 
		
	Deep Fork Capital L.L.C.	  	QCP Fund A
		
	Sequoia Capital XII, L.P.	  	Accel IX L.P.
		
	Accel IX Strategic Partners L.P.	  	Accel Investors 2005 L.L.C.
		
	Fayez Sarofim Investment Partnership #5, LP	  	

 EXHIBIT E 

SCHEDULE OF COMMON HOLDERS 
  

					
	 Name
	  	Number of Common Shares	 
		
	 Peter Flint
	  	 	2,666,404	  
		
	 Sami Markus Inkinen
	  	 	2,082,810	  
		  	  
	  
	 
		
	 Total:
	  	 	4,749,214

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00207-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00207-of-00352.parquet"}]]